Table of Contents
 
 Exhibit (a)(1)(i)​
OFFER TO EXCHANGE
OUTSTANDING SHARES OF COMMON STOCK
FOR
SHARES OF 12.00% JUNIOR SERIES B PARTICIPATING CUMULATIVE REDEEMABLE PREFERRED STOCK
OF
REDWOOD TRUST, INC.
​ ​ THE EXCHANGE OFFER PERIOD AND YOUR RIGHT TO WITHDRAW SHARES OF COMMON STOCK THAT YOU TENDER WILL EXPIRE AT ONE MINUTE FOLLOWING 11:59 P.M. (12:00 MIDNIGHT), NEW YORK CITY TIME, ON DECEMBER 15, 2026 UNLESS THE EXCHANGE OFFER PERIOD IS EXTENDED OR EARLIER TERMINATED. REDWOOD TRUST, INC. MAY EXTEND THE EXCHANGE OFFER PERIOD AT ANY TIME. ​ ​
Redwood Trust, Inc., a Maryland corporation (the “Company”, “our”, “we”, “us” or “Redwood”), is offering to exchange up to 17,360,000 of the currently issued and outstanding shares of common stock of the Company, par value $0.01 per share (NYSE: RWT) (the “Common Stock”), for newly issued shares of the Company’s 12.00% Junior Series B Participating Cumulative Redeemable Preferred Stock, par value $0.01 per share and liquidation preference stated at $25.00 per share for purposes of determining dividends (the “Junior Series B Participating Preferred Stock”), with each 7.58 shares of Common Stock (the “Exchange Ratio”) being exchangeable for 1 share of Junior Series B Participating Preferred Stock, on the terms and subject to the conditions set forth in this offer to exchange (this “Offer to Exchange”) and in the accompanying letter of transmittal (the “Letter of Transmittal”), each as may be amended or supplemented from time to time. We refer to this offer, on the terms and subject to the conditions set forth in this Offer to Exchange, as the “Exchange Offer.”
For Each:
​ ​
Consideration to be Received:
​
7.58 shares of Common Stock, par value $0.01 per share ​ ​ 1 share of Junior Series B Participating Preferred Stock, par value $0.01 per share and liquidation preference stated at $25.00 per share ​
The “Exchange Offer Period” is the period commencing on November 17, 2026 and ending at one minute following 11:59 P.M. (12:00 midnight), New York City Time, on December 15, 2026, or such later date to which the Company may extend the Exchange Offer (the “Expiration Date”). The Exchange Offer is conditioned on the valid tender (without valid withdrawal) of at least 8,680,000 shares of Common Stock, as well as the other conditions described under “The Exchange Offer — Conditions to the Exchange Offer.” If any of the offer conditions are not met, we may amend, terminate or extend the Exchange Offer.
Following the consummation of the Exchange Offer, each share of Common Stock that was not tendered or was tendered and returned to holders will continue to be outstanding and otherwise unaffected by the Exchange Offer, other than being subordinate to the Junior Series B Participating Preferred Stock in right of payment of dividends and distributions and upon liquidation.
The Junior Series B Participating Preferred Stock has no stated maturity and ranks senior to the Common Stock and our Series X Preferred Stock (as defined below), junior to our Series A Preferred Stock (as defined below) and effectively junior to all existing and future indebtedness. Holders of the Junior Series B Participating Preferred Stock will be entitled to receive cumulative cash dividends at a fixed rate of 12.00% per annum based on the stated $25.00 per share liquidation preference, payable quarterly in arrears, which is cumulative from the date of original issuance (the “Original Issuance Date”), when, as and if authorized by our Board of Directors and declared by the Company, on the 15th day of each January, April, July and October (each, a “Dividend Payment Date”).
The Junior Series B Participating Preferred Stock will be redeemable by the Company for the Optional Redemption Price (as defined below), on and after the first anniversary of the Original Issuance Date. The Company may also redeem the Junior Series B Participating Preferred Stock upon a Change of Control (as defined below), to preserve its REIT (as defined below) status or pursuant to the ownership limitation
 

Table of Contents
 
described herein, even if prior to the first anniversary of the Original Issuance Date. Each outstanding share of Junior Series B Participating Preferred Stock not redeemed by the Company will automatically convert into shares of Common Stock upon a Change of Control, subject to the Share Cap (as defined below). Except in connection with a Change of Control, the Junior Series B Participating Preferred Stock is not convertible into Common Stock. Upon any voluntary or involuntary liquidation, dissolution or winding up, holders of the Junior Series B Participating Preferred Stock will be entitled to be paid a price equal to the Optional Redemption Price (with the references to redemption in such definition replaced with the relevant voluntary or involuntary liquidation, dissolution or winding up).
The Junior Series B Participating Preferred Stock will vote together with the Common Stock on any matter on which holders of Common Stock are entitled to vote, and, in voting on such matters, each share of Junior Series B Participating Preferred Stock will carry a number of votes equal to the Exchange Ratio, being the number of shares of Common Stock exchanged for each share of Junior Series B Participating Preferred Stock in this Exchange Offer, subject to customary adjustments for future stock splits.
The articles supplementary setting forth the terms of the Junior Series B Participating Preferred Stock (the “Articles Supplementary”) will prohibit any person from beneficially or constructively owning more than 4.9% of the outstanding Junior Series B Participating Preferred Stock, except for holders who acquire more than 4.9% by tendering Common Stock currently held by them pursuant to this Exchange Offer.
The form of Articles Supplementary, which includes all of the terms of the Junior Series B Participating Preferred Stock, will be filed with an amendment to the Schedule TO-I of which this Offer to Exchange forms a part. Please see the section entitled “Description of Junior Series B Participating Cumulative Redeemable Preferred Stock” in this Offer to Exchange for a description of the rights, privileges and preferences of the Junior Series B Participating Preferred Stock.
We are authorized to issue up to 395,000,000 shares of capital stock. Our charter authorizes our Board of Directors to classify from time to time any unissued shares of stock in one or more classes or series of preferred stock. As of November 16, 2026, 391,615,000 shares of capital stock were classified as Common Stock, 2,990,000 shares of capital stock were classified as 10.00% Series A Fixed-Rate Reset Cumulative Redeemable Preferred Stock, par value $0.01 per share (“Series A Preferred Stock”) and 395,000 shares were classified as Series X Junior Participating Preferred Stock. Our Board of Directors and a pricing committee thereof have authorized, in connection with this Exchange Offer, the classification of our unissued shares of capital stock as Junior Series B Participating Preferred Stock.
Our shares of Common Stock are listed on the New York Stock Exchange (“NYSE”) under the symbol “RWT.” Application will be made to list the Junior Series B Participating Preferred Stock on the NYSE. If the application is approved, the Junior Series B Participating Preferred Stock is expected to commence trading on the NYSE within thirty days of the date of issuance.
You should consider carefully the “Risk Factors” in this Offer to Exchange and the other information included herein before you decide whether to participate in the Exchange Offer. Our Board of Directors has authorized us to make the Exchange Offer. Our Board of Directors is not making any recommendation as to whether or not you should tender your shares of Common Stock for exchange in the Exchange Offer, and has not made any specific determination as to the value of the consideration to be received by tendering stockholders. Accordingly, you must make your own decision as to whether to tender shares of Common Stock in the Exchange Offer in light of your own particular circumstances, taking into account your determination as to the value of the consideration to be received.
NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE JUNIOR SERIES B PARTICIPATING PREFERRED STOCK OR DETERMINED IF THIS OFFER TO EXCHANGE IS ACCURATE OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THE EXCHANGE OFFER, PASSED UPON THE MERITS OR FAIRNESS OF THE EXCHANGE OFFER OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURES IN THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
 
ii

Table of Contents
 
The Exchange Offer is conditioned on, among other things, the Minimum Tender Condition (as defined herein), as described herein.
You may tender some or all of your shares of Common Stock on these terms. If you elect to tender shares of Common Stock in response to the Exchange Offer, please follow the instructions in this Offer to Exchange and the related documents, including the Letter of Transmittal.
If you tender shares of Common Stock, you may withdraw your tendered shares of Common Stock before the Expiration Date and retain them on their terms by following the instructions herein.
Investing in the Junior Series B Participating Preferred Stock involves a high degree of risk. Please see the section entitled “Risk Factors” of this Offer to Exchange for a discussion of information that you should consider before tendering shares of Common Stock in the Exchange Offer.
The Exchange Offer will commence on November 17, 2026 and will end on the Expiration Date.
A detailed discussion of the Exchange Offer is contained in this Offer to Exchange. Holders of Common Stock are strongly encouraged to read this entire package of materials, and the publicly filed information about the Company referenced herein, before making a decision regarding the Exchange Offer.
November 17, 2026
 
iii

Table of Contents​
 
IMPORTANT PROCEDURES
If you want to tender some or all of your shares of Common Stock for shares of the Company’s Junior Series B Participating Preferred Stock, you must do one of the following before the Expiration Date:
•
if your shares of Common Stock are registered in the name of a broker, dealer, commercial bank, trust company, or other nominee, contact the nominee and have the nominee tender your shares of Common Stock for you, which typically can be done electronically;
​
•
if you hold Common Stock certificates in your own name, complete and sign the appropriate enclosed Letter of Transmittal according to its instructions, and deliver it, together with any required signature guarantees, the certificates for your shares of Common Stock, and any other documents required by the Letter of Transmittal, to the Exchange Agent; or
​
•
if you are an institution participating in The Depository Trust Company (“DTC”), you must tender your shares of Common Stock according to the procedure for book-entry transfer described in “The Exchange Offer — Procedures for Tendering Shares of Common Stock” of this Offer to Exchange.
​
To validly tender shares of Common Stock pursuant to the Exchange Offer, other than shares of Common Stock registered in the name of a broker, dealer, commercial bank, trust company or other nominee, you must properly complete and duly execute the Letter of Transmittal and deliver it to the Exchange Agent in accordance with the procedures described in this Offer to Exchange.
No fractional shares of Junior Series B Participating Preferred Stock will be issued. Shares of Common Stock may only be exchanged for whole shares of Junior Series B Participating Preferred Stock. In lieu of issuing fractional shares of Junior Series B Participating Preferred Stock, we will round down the number of shares of Junior Series B Participating Preferred Stock to which such holder is entitled, after aggregating all fractions, to the nearest whole share of Junior Series B Participating Preferred Stock, and the amount of consideration that would otherwise have been represented by such fractional shares of Junior Series B Participating Preferred Stock will be paid in cash to the tendering stockholders, as described in “The Exchange Offer — General.”
We are not making the Exchange Offer to, and will not accept any tendered shares of Common Stock from, stockholders in any jurisdiction where it would be illegal to do so. However, we may, at our discretion, take any actions necessary for us to comply with the applicable laws and regulations to make the Exchange Offer to stockholders in any such jurisdiction.
We have not authorized any person to make any recommendation on our behalf as to whether you should tender or refrain from tendering your shares of Common Stock pursuant to the Exchange Offer. You should rely only on the information contained in this Offer to Exchange and in the related Letter of Transmittal or to which we have referred you. We have not authorized anyone to provide you with information or to make any representation in connection with the Exchange Offer other than those contained in this Offer to Exchange or in the related Letter of Transmittal. If anyone makes any recommendation or gives any information or representation regarding the Exchange Offer, you must not rely upon that recommendation, information or representation as having been authorized by us or our Board of Directors for the Exchange Offer. You should not assume that the information provided in this Offer to Exchange is accurate as of any date other than the date as of which it is shown, or if no date is otherwise indicated, the date of this Offer to Exchange. We recommend that stockholders consult their financial and tax advisors, and read carefully and evaluate the information in this Offer to Exchange and in the Letter of Transmittal before taking any action with respect to the Exchange Offer.
We are relying on Section 3(a)(9) of the Securities Act to exempt the Exchange Offer from the registration requirements of the Securities Act. We are also relying on Section 18(b)(4)(E) of the Securities Act to exempt the Exchange Offer from state securities law requirements. We have no contract, arrangement, or understanding relating to the payment of, and will not, directly or indirectly, pay, any commission or other remuneration to any broker, dealer, salesperson, agent, or any other person for soliciting tenders in the Exchange Offer. In addition, none of the Exchange Agent, Information Agent, or any broker, dealer, salesperson, agent, or any other person, is engaged or authorized to express any statement, opinion, recommendation, or judgment with respect to the relative merits and risks of the Exchange Offer. Our
 
iv

Table of Contents
 
officers, directors, and regular employees may solicit tenders from stockholders and will answer inquiries concerning the terms of the Exchange Offer, but they will not receive additional compensation for soliciting tenders or answering any such inquiries.
All inquiries relating to this Offer to Exchange should be directed to MacKenzie Partners, Inc., the Information Agent for the Exchange Offer, at the telephone number or the email address listed on the back cover page of this Offer to Exchange. Questions regarding the procedures for tendering in the Exchange Offer and requests for assistance in tendering your certificated shares of Common Stock should be directed to Computershare Trust Company, N.A., the Exchange Agent, at the toll-free number (888) 472-1955. Requests for additional copies of this Offer to Exchange, any documents incorporated by reference into this Offer to Exchange or the Letter of Transmittal may be directed to the Information Agent at the telephone number and address listed on the back cover page of this Offer to Exchange.
 
v

Table of Contents​
 
TABLE OF CONTENTS
​ ​ ​
Page
​
​ ​ ​ ​ iv ​ ​
​ ​ ​ ​ 1 ​ ​
​ ​ ​ ​ 6 ​ ​
​ ​ ​ ​ 12 ​ ​
​ ​ ​ ​ 15 ​ ​
​ ​ ​ ​ 25 ​ ​
​ ​ ​ ​ 34 ​ ​
​ ​ ​ ​ 46 ​ ​
​ ​ ​ ​ 50 ​ ​
​ ​ ​ ​ 51 ​ ​
​ ​ ​ ​ 56 ​ ​
​ ​ ​ ​ 57 ​ ​
​ ​ ​ ​ 58 ​ ​
​ ​ ​ ​ 58 ​ ​
 
i

Table of Contents​
 
SUMMARY
The following is a summary of the terms of the Exchange Offer being provided for your convenience. It highlights certain material information in this Offer to Exchange, but before you make any decision with respect to the Exchange Offer, we urge you to read carefully this entire Offer to Exchange, including the section entitled “Risk Factors,” the related Letter of Transmittal, the descriptions of Common Stock and Junior Series B Participating Preferred Stock and the documents incorporated by reference into this Offer to Exchange. Our Annual Report on Form 10-K for the year ended December 31, 2025 (the “Annual Report”), subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K are available online at the SEC website (www.sec.gov), and are also available from us upon request. See “Available Information.” The following summary is qualified in its entirety by the more detailed information appearing elsewhere in this Offer to Exchange and the related Letter of Transmittal.
The Company
Redwood Trust, Inc., a Maryland corporation.
The Exchange Offer
We are offering to exchange shares of Common Stock for shares of Junior Series B Participating Preferred Stock. For each 7.58 shares of Common Stock validly tendered and not validly withdrawn, we will issue 1 share of Junior Series B Participating Preferred Stock. If all conditions to the Exchange Offer are satisfied or waived, we will exchange up to 17,360,000 shares of outstanding Common Stock from all tendering holders. However, only whole shares of Junior Series B Participating Preferred Stock will be delivered.
A holder may tender as few or as many shares of Common Stock as the holder elects. If more than 17,360,000 shares of Common Stock are validly tendered and not validly withdrawn prior to the Expiration Date, we will exchange shares of Junior Series B Participating Preferred Stock for shares of Common Stock, subject to the terms of the Exchange Offer, of all stockholders on a pro rata basis from all shares of Common Stock tendered for exchange.
Shares of Common Stock may only be exchanged for whole shares of Junior Series B Participating Preferred Stock. In lieu of issuing fractional shares of Junior Series B Participating Preferred Stock to which any holder of shares of Common Stock would otherwise have been entitled, the Company will round down the number of shares of Junior Series B Participating Preferred Stock to which such holder is entitled, after aggregating all fractions, to the nearest whole number of shares of Junior Series B Participating Preferred Stock, and the amount of consideration that would otherwise have been represented by such fractional share of Junior Series B Participating Preferred Stock will be paid in cash to the tendering stockholders in an amount equal to the corresponding liquidation preference of such fractional share.
The Exchange Offer is being made exclusively to existing holders of shares of Common Stock.
Please see “The Exchange Offer” for additional information.
If you have questions, please call the Information Agent at the telephone number below. See “The Exchange Offer — Procedures for Tendering Shares of Common Stock.”
The Common Stock
As of November 16, 2026, we had 116,893,393 shares of Common Stock issued and outstanding. Our shares of Common Stock are listed on the NYSE under the symbol “RWT.”
 
1

Table of Contents
 
The last reported closing sale price of our shares of Common Stock as reported by the NYSE on November 16, 2026, the last trading day before the date of this Offer to Exchange, was $2.88 per share.
The Junior Series B Participating Preferred Stock
As of November 16, 2026, we had no shares of Junior Series B Participating Preferred Stock outstanding.
We intend to file an application to list the Junior Series B Participating Preferred Stock on the NYSE under the symbol “RWT PRB”, and, if the application is approved, trading of the Junior Series B Participating Preferred Stock on the NYSE is expected to commence within thirty days after the date of initial delivery of the Junior Series B Participating Preferred Stock.
The Junior Series B Participating Preferred Stock has no stated maturity and ranks senior to the Common Stock and our Series X Preferred Stock, junior to our Series A Preferred Stock and effectively junior to all existing and future indebtedness. Holders of the Junior Series B Participating Preferred Stock will be entitled to receive cumulative cash dividends at a fixed rate of 12.00% per annum based on the stated $25.00 per share liquidation preference, payable quarterly in arrears, which is cumulative from the Original Issuance Date, when, as and if authorized by our Board of Directors and declared by the Company, on the 15th day of each January, April, July and October.
The Junior Series B Participating Preferred Stock will be redeemable by the Company on and after the first anniversary of the Original Issuance Date for cash at a redemption price per share equal to the greater of:
(i)
an amount equal to:
​
(x) the arithmetic average of the VWAP (as defined below) of the Common Stock for the 5 consecutive trading days commencing on the 11th trading day following the commencement of this Exchange Offer (the “Original Issuance Common Stock Price”) multiplied by the Exchange Ratio (the “Initial Exchanged Value”);
multiplied by
(y) a factor of 1 + (70% multiplied by [(the arithmetic average of the VWAP of the Common Stock for the 5 consecutive trading days commencing on the 11th trading day following the announcement of the relevant redemption (subject to customary adjustments for future stock splits) divided by the Original Issuance Common Stock Price) minus one]); and
(ii)
the Initial Exchanged Value;
​
in each case, less cumulative dividends already paid and accrued and unpaid dividends thereon to, but not including, the date fixed for redemption on such share, subject to a floor of $0, plus accrued and unpaid dividends thereon to, but not including, the date fixed for redemption (such redemption price, the “Optional Redemption Price”).
 
2

Table of Contents
 
The Company may also redeem the Junior Series B Participating Preferred Stock at the Optional Redemption Price upon a Change of Control, to preserve its REIT status or pursuant to the ownership limitation described herein, even if prior to the first anniversary of the Original Issuance Date. Each outstanding share of Junior Series B Participating Preferred Stock not redeemed by the Company will automatically convert into shares of Common Stock upon a Change of Control, subject to the Share Cap. Except in connection with a Change of Control, the Junior Series B Participating Preferred Stock is not convertible into Common Stock. Upon any voluntary or involuntary liquidation, dissolution or winding up, holders of the Junior Series B Participating Preferred Stock will be entitled to be paid a price equal to the Optional Redemption Price (with the references to redemption in such definition replaced with the relevant voluntary or involuntary liquidation, dissolution or winding up).
The Junior Series B Participating Preferred Stock will vote together with the Common Stock on any matter on which holders of Common Stock are entitled to vote, and, in voting on such matters, each share of Junior Series B Participating Preferred Stock will carry a number of votes equal to the Exchange Ratio, being the number of shares of Common Stock exchanged for each share of Junior Series B Participating Preferred Stock in this Exchange Offer, subject to customary adjustments for future stock splits.
The Articles Supplementary will prohibit any person from beneficially or constructively owning more than 4.9% of the outstanding Junior Series B Participating Preferred Stock, except for holders who acquire more than 4.9% by tendering Common Stock currently held by them pursuant to this Exchange Offer. Under our Tax Benefits Preservation Plan, any person or group, other than certain exempt or grandfathered persons, together with its affiliates and associates, that acquires ownership of 4.9% or more of the combined value of the Junior Series B Participating Preferred Stock and the Common Stock (or of the then-outstanding shares of Common Stock) without the approval of the Board of Directors may suffer substantial dilution of its ownership interest in the Company.
Please see the section entitled “Description of Junior Series B Participating Cumulative Redeemable Preferred Stock” in this Offer to Exchange for a description of the rights, privileges and preferences of our Junior Series B Participating Preferred Stock.
No Recommendation
Neither we, our Board of Directors, the Exchange Agent, the Information Agent, nor any affiliate of any of the foregoing or any other person is making any recommendation as to whether or not you should tender your shares of Common Stock in the Exchange Offer. We have not authorized any person to make such a recommendation. You must make your own investment decision regarding the Exchange Offer based upon your own assessment of the market value of the shares of Common Stock and the Junior Series B Participating Preferred Stock, your liquidity needs, your investment objectives and any other factors you deem relevant.
Conditions to the Consummation of the Exchange Offer
A detailed discussion of the general conditions to the consummation of the Exchange Offer is contained in “The Exchange Offer —  Conditions to the Exchange Offer.”
 
3

Table of Contents
 
Expiration Date of Offer
One minute following 11:59 P.M. (12:00 midnight), New York City Time, on December 15, 2026, or such later date to which we may extend the Exchange Offer. All shares of Common Stock and related paperwork must be received by the Exchange Agent by this time, as instructed herein. See “The Exchange Offer — Expiration; Extensions; Termination; Amendment.”
Withdrawal Rights
If you tender your shares of Common Stock and change your mind, you may withdraw your tendered shares of Common Stock at any time until the Expiration Date, as described in greater detail in “The Exchange Offer-Withdrawal Rights.”
Appraisal Rights
Holders of Common Stock are not entitled to appraisal rights in connection with the Exchange Offer.
Information Agent
MacKenzie Partners, Inc.
Exchange Agent
Computershare Trust Company, N.A.
Recent Developments
Plan for C-Corp. Conversion
On November 3, 2026, we announced that our Board of Directors unanimously approved a plan to revoke the Company’s election to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes in the first quarter of 2027 and transition to a C corporation beginning with its 2027 taxable year (the “C-Corp. Conversion Plan”). The C-Corp. Conversion Plan will not be completed until the Company makes a filing with the Internal Revenue Service (“IRS”) to revoke the Company’s election to be taxed as a REIT pursuant to Section 856(g)(2) of the Internal Revenue Code of 1986, as amended (the “Code”), for the taxable year ending December 31, 2027 (the “REIT Status Revocation Filing”). We currently expect to make the REIT Status Revocation Filing with the IRS on or prior to March 31, 2027. As a result of the REIT Status Revocation Filing, the Company would become a taxable C corporation effective January 1, 2027. Under the C-Corp. Conversion Plan, the Board of Directors has determined that it is in the Company’s best interests to continue to maintain its REIT status for the taxable year ending December 31, 2026, and to remain in compliance with the requirements for taxation as a REIT during 2027 until such time as the Company makes the REIT Status Revocation Filing.
Adoption of Tax Benefits Preservation Plan
On November 3, 2026, our Board of Directors adopted a Tax Benefits Preservation Plan (the “Tax Benefits Preservation Plan”) and declared a dividend of one right (a “Right”) for each outstanding share of Common Stock, to stockholders of record at the close of business on November 16, 2026 (the “Record Date”). Each Right entitles its holder, subject to the terms of the Tax Benefits Preservation Plan, to purchase from the Company one one-thousandth of a share of Series X Junior Participating Preferred Stock, par value $0.01 per share (“Series X Preferred Stock”), of the Company at an exercise price of $20.00 per Right, subject to adjustment.
Under our Tax Benefits Preservation Plan, any person or group, other than certain exempt or grandfathered persons, together with its affiliates and associates, that acquires ownership of 4.9% or more of the combined value of the Junior Series B Participating Preferred Stock and the Common Stock (or of the then-outstanding shares of Common Stock) without the approval of the Board of Directors may suffer substantial dilution of its ownership interest in the Company. As a result, for any holder of 4.9% or more of the Junior Series B Participating Preferred Stock, aggregate ownership of 4.9% or more of the combined value of the holder’s Junior Series B Participating Preferred Stock and Common Stock could result from an acquisition of Common Stock even if Common Stock ownership is less than 4.9% of then-outstanding shares.
 
4

Table of Contents
 
Reverse Stock Split
On November 3, 2026, we announced that our Board of Directors unanimously approved a reverse stock split of our outstanding shares of Common Stock, at a ratio of one-for-five (the “Reverse Stock Split”). The Reverse Stock Split is expected to take effect at 5:00 p.m., New York City Time, on December 31, 2026 (the “Effective Time”). As a result of the Reverse Stock Split, at the Effective Time, every five (5) issued and outstanding shares of Common Stock, par value $0.01 per share, will be converted into one share of Common Stock, par value $0.05 per share. The charter amendment effecting the Reverse Stock Split will further provide that the par value of the outstanding shares of Common Stock will be changed from $0.05 per share (as a result of the Reverse Stock Split) back to $0.01 per share. Trading in the Common Stock on a split-adjusted basis is expected to begin at the market open on January 4, 2027.
For more information regarding the C-Corp. Conversion Plan, the Tax Benefits Preservation Plan and the Reverse Stock Split, please refer to the Company’s Current Report on Form 8-K filed with the SEC on November 3, 2026.
 
5

Table of Contents​
 
CERTAIN QUESTIONS AND ANSWERS ABOUT THE EXCHANGE OFFER
The following questions and answers are for your convenience only, and briefly address some commonly asked questions about the Exchange Offer. We urge you to read carefully this entire Offer to Exchange, including the section entitled “Risk Factors,” the section entitled “Material Differences Among the Common Stock, Series A Preferred Stock and Junior Series B Participating Preferred Stock,” the related Letter of Transmittal, and the other documents incorporated by reference into this Offer to Exchange.
Q:
Why am I receiving these materials?
​
A:
We are providing these materials to provide you with information regarding our offer to exchange outstanding shares of Common Stock that you currently hold for shares of our Junior Series B Participating Preferred Stock.
​
Q:
Under what circumstances may the Exchange Offer be terminated, and what happens to my tendered shares of Common Stock if that occurs?
​
A:
The Exchange Offer may be terminated if the conditions, such as the Minimum Tender Condition, to the Exchange Offer discussed in this Offer to Exchange are not satisfied or waived. If the Exchange Offer is terminated and you previously have tendered shares of Common Stock, such tendered shares of Common Stock will be credited back to an appropriate account promptly following the termination of the Exchange Offer without expense to you. See “The Exchange Offer.”
​
Q:
What are the effects of the Exchange Offer on the ownership structure of Redwood Trust, Inc.?
​
A:
The main effect that the Exchange Offer could have is that holders of shares of Common Stock who do not exchange their shares will see their percentage ownership of our outstanding shares of Common Stock increase, and those interests will be subordinated to the Junior Series B Participating Preferred Stock in respect of dividends and rights upon liquidation. In addition, depending on the number of stockholders that elect to tender some or all of their shares of Common Stock in the Exchange Offer, there may be fewer shares of Common Stock held by non-affiliated stockholders, and there will therefore likely be fewer transactions in the shares of Common Stock resulting in lower liquidity, which could result in decreased prices of the shares of Common Stock.
​
Q:
How will I be notified if the Exchange Offer is extended, amended or terminated?
​
A:
We, in our sole discretion, may extend the Expiration Date for any reason. If the Exchange Offer is extended, amended or terminated, we will promptly make a public announcement by issuing a press release. In the case of an extension, the announcement will be issued no later than 9:00 a.m., New York City Time, on the next business day after the previously scheduled expiration date of the Exchange Offer. See “The Exchange Offer — Expiration; Extensions; Termination; Amendment.”
​
Q:
What will I receive in the Exchange Offer if I tender my shares of Common Stock and they are accepted?
​
A:
You will receive 1 share of Junior Series B Participating Preferred Stock for each 7.58 shares of Common Stock validly tendered and not validly withdrawn, unless more than 17,360,000 shares of Common Stock are tendered, in which case the shares of Junior Series B Participating Preferred Stock will be allocated on a pro rata basis.
​
In lieu of issuing fractional shares of Junior Series B Participating Preferred Stock, we will round down the number of shares of Junior Series B Participating Preferred Stock to which such holder is entitled, after aggregating all fractions, to the nearest whole number of shares of Junior Series B Participating Preferred Stock, and the amount of consideration that would otherwise have been represented by such fractional share of Junior Series B Participating Preferred Stock will be paid in cash to the tendering stockholders in an amount equal to the corresponding liquidation preference of such fractional share.
 
6

Table of Contents
 
Q:
How many shares of Common Stock are sought to be tendered in the Exchange Offer?
​
A:
We are offering to exchange up to 17,360,000 shares of Common Stock, representing approximately 14.9% of our outstanding shares of Common Stock. The Exchange Offer is conditioned on, among other things, the valid tender (without valid withdrawal) of at least 8,680,000 shares of Common Stock prior to the Expiration Date.
​
Q:
What happens if stockholders tender more than 17,360,000 shares of Common Stock?
​
A:
If stockholders tender more than 17,360,000 shares of Common Stock, we will exchange shares on a pro rata basis. This means that we will exchange from you a number of shares calculated by multiplying the number of shares you validly tendered by a proration factor. The proration factor will equal 17,360,000 divided by the total number of shares validly tendered and not withdrawn. We will make adjustments to avoid exchanges of fractional shares. For information about the proration procedures of the Exchange Offer, see “The Exchange Offer — General.”
​
Q:
If you prorate, when will I know how many shares of Common Stock will actually be exchanged?
​
A:
If proration of the tendered shares of Common Stock is required, we do not expect to announce the final results of proration or exchange for any shares until approximately five trading days after the expiration of the Exchange Offer. This is because we will not know the precise number of shares of Common Stock validly tendered (and not withdrawn) until all supporting documentation for those tenders is reviewed. For information about the proration procedures of the Exchange Offer, see “The Exchange Offer — General.”
​
Q:
What are the terms of the Junior Series B Participating Preferred Stock?
​
A:
The Junior Series B Participating Preferred Stock has no stated maturity and ranks senior to the Common Stock and our Series X Preferred Stock, junior to our Series A Preferred Stock and effectively junior to all existing and future indebtedness. Holders of the Junior Series B Participating Preferred Stock will be entitled to receive cumulative cash dividends at a fixed rate of 12.00% per annum based on the stated $25.00 per share liquidation preference, payable quarterly in arrears, which is cumulative from the Original Issuance Date, when, as and if authorized by our Board of Directors and declared by the Company, on the 15th day of each January, April, July and October.
​
The Junior Series B Participating Preferred Stock will be redeemable by the Company for the Optional Redemption Price on and after the first anniversary of the Original Issuance Date. The Company may also redeem the Junior Series B Participating Preferred Stock upon a Change of Control, to preserve its REIT status or pursuant to the ownership limitation described herein, even if prior to the first anniversary of the Original Issuance Date. Each outstanding share of Junior Series B Participating Preferred Stock not redeemed by the Company will automatically convert into shares of Common Stock upon a Change of Control, subject to the Share Cap. Except in connection with a Change of Control, the Junior Series B Participating Preferred Stock is not convertible into Common Stock. Upon any voluntary or involuntary liquidation, dissolution or winding up, holders of the Junior Series B Participating Preferred Stock will be entitled to be paid a price equal to the Optional Redemption Price (with the references to redemption in such definition replaced with the relevant voluntary or involuntary liquidation, dissolution or winding up).
The Junior Series B Participating Preferred Stock will vote together with the Common Stock on any matter on which holders of Common Stock are entitled to vote, and, in voting on such matters, each share of Junior Series B Participating Preferred Stock will carry a number of votes equal to the Exchange Ratio, being the number of shares of Common Stock exchanged for each share of Junior Series B Participating Preferred Stock in this Exchange Offer, subject to customary adjustments for future stock splits.
The Articles Supplementary will prohibit any person from beneficially or constructively owning more than 4.9% of the outstanding Junior Series B Participating Preferred Stock, except for holders who
 
7

Table of Contents
 
acquire more than 4.9% by tendering Common Stock currently held by them pursuant to this Exchange Offer. Under our Tax Benefits Preservation Plan, any person or group, other than certain exempt or grandfathered persons, together with its affiliates and associates, that acquires ownership of 4.9% or more of the combined value of the Junior Series B Participating Preferred Stock and the Common Stock (or of the then-outstanding shares of Common Stock) without the approval of the Board of Directors may suffer substantial dilution of its ownership interest in the Company.
Please see the section entitled “Description of Junior Series B Participating Cumulative Redeemable Preferred Stock” in this Offer to Exchange for a description of the rights, privileges and preferences of our Junior Series B Participating Preferred Stock.
Q:
Will the redemption or liquidation price for each share of the Junior Series B Participating Preferred Stock be equal to the stated $25.00 liquidation preference per share? Will the value of the shares of Common Stock a holder receives upon conversion of one share of Junior Series B Participating Preferred Stock in a Change of Control be equal to the $25.00 stated liquidation preference per share?
​
A:
If we redeem the Junior Series B Participating Preferred Stock, including in connection with a Change of Control, or if the Company undergoes an involuntary or voluntary liquidation, dissolution or winding up, holders will be entitled to receive, for each share, a cash payment equal to the Optional Redemption Price. The Optional Redemption Price may be less than the stated $25.00 per share liquidation preference of the Junior Series B Participating Preferred Stock.
​
Upon the occurrence of a Change of Control, all outstanding shares of Junior Series B Participating Preferred Stock not previously redeemed by the Company will automatically convert into shares of Common Stock (or the equivalent value of Alternative Conversion Consideration (as defined herein)) based on the five-day VWAP of the Common Stock prior to the date on which the Change of Control occurred, subject to a maximum number of shares of Common Stock (or, if applicable, Alternative Conversion Consideration) equal to the Share Cap multiplied by the number of shares of Junior Series B Participating Preferred Stock converted, which may result in a holder receiving a value per share of Junior Series B Participating Preferred Stock that is less than the stated $25.00 per share liquidation preference. See “Risk Factors — Risks Related to the Junior Series B Participating Preferred Stock.”
Q:
How will the Optional Redemption Price per share of Junior Series B Participating Preferred Stock change with movements in the price of the Common Stock?
​
A:
Below are illustrative examples of how the Optional Redemption Price per share of Junior Series B Participating Preferred Stock would vary based on three different scenarios for movements in the price of the Common Stock. In each scenario, we assume that the second anniversary of the Original Issuance Date is the date fixed for determining the Optional Redemption Price and, therefore, that the cumulative paid dividends as of such date would be $6.00 and there would not be any accrued and unpaid dividends as of such date. Each scenario also assumes that the price of the Common Stock has been subject to customary adjustments for future stock splits.
​
The Optional Redemption Price is equal to the greater of:
(i)
an amount equal to:
​
(x)
the arithmetic average of the VWAP of the Common Stock for the 5 consecutive trading days commencing on the 11th trading day following the commencement of this Exchange Offer (the “Original Issuance Common Stock Price”) multiplied by the Exchange Ratio (the “Initial Exchanged Value”);
​
multiplied by
(y)
a factor of 1 + (70% multiplied by [(the arithmetic average of the VWAP of the Common Stock for the 5 consecutive trading days commencing on the 11th trading day following the announcement of the relevant redemption (subject to customary adjustments for future stock splits, the “Ending Common Stock Price”) divided by the Original Issuance Common Stock Price) minus one]); and
​
​
 
8

Table of Contents
 
(ii)
the Initial Exchanged Value;
​
in each case, less cumulative dividends already paid and accrued and unpaid dividends thereon to, but not including, the date fixed for redemption on such share, subject to a floor of $0, plus accrued and unpaid dividends thereon to, but not including, the date fixed for redemption.
Illustrative Scenario 1  — The Ending Common Stock Price is double the Original Issuance Common Stock Price.
If we assume that the Original Issuance Common Stock Price is $3.00 and the Ending Common Stock Price is $6.00 (after customary adjustments for future stock splits), then the Initial Exchanged Value would be approximately $22.74 and the value in clause (i) of the Optional Redemption Price would be approximately $38.66. Therefore, after deducting the $6.00 of cumulative paid dividends from $38.66, the effective Optional Redemption Price in this illustrative scenario would be approximately $32.66.
Illustrative Scenario 2 — The Ending Common Stock Price is equal to the Original Issuance Common Stock Price.
If we assume that the Original Issuance Common Stock Price is $3.00 and the Ending Common Stock Price is $3.00 (after customary adjustments for future stock splits), the value in clause (i) of the Optional Redemption Price and the Initial Exchanged Value in clause (ii) of the Optional Redemption Price would both be approximately $22.74. Therefore, after deducting the $6.00 of cumulative paid dividends from $22.74, the effective Optional Redemption Price in this illustrative scenario would be approximately $16.74.
Illustrative Scenario 3 — The Ending Common Stock Price is 33% lower than the Original Issuance Common Stock Price.
If we assume that the Original Issuance Common Stock Price is $3.00 and the Ending Common Stock Price is $2.00 (after customary adjustments for future stock splits), the value in clause (i) of the Optional Redemption Price would be approximately $17.43 and the Initial Exchanged Value in clause (ii) of the Optional Redemption Price would be approximately $22.74. Because the Optional Redemption Price selects the greater of clauses (i) and (ii), the Initial Exchanged Value of approximately $22.74 would apply. Therefore, after deducting the $6.00 of cumulative paid dividends from $22.74, the effective Optional Redemption Price in this illustrative scenario would be approximately $16.74, the same as in Illustrative Scenario 2.
Q:
What are the tax consequences of the Exchange Offer to me?
​
A:
The U.S. federal income tax consequences to you of participating in the Exchange Offer are complex and may vary depending on certain facts and circumstances. We intend to treat the exchange of your shares of Common Stock for Junior Series B Participating Preferred Stock as a “recapitalization” within the meaning of Section 368(a)(1)(E) of the Code pursuant to which (i) you should not recognize any gain or loss on the exchange of your shares of Common Stock for Junior Series B Participating Preferred Stock (other than with respect to any cash received in lieu of a fractional share of Junior Series B Participating Preferred Stock), (ii) your aggregate tax basis in Junior Series B Participating Preferred Stock received in the exchange should equal your aggregate tax basis in your shares of Common Stock surrendered in the exchange (except to the extent of any tax basis allocated to a fractional share of Junior Series B Participating Preferred Stock for which a cash payment is received in connection with the exchange), and (iii) your holding period for shares of Junior Series B Participating Preferred Stock received in the exchange should include your holding period for the surrendered Common Stock. However, alternative characterizations by the IRS or a court are possible, including ones that would require U.S. holders to recognize taxable income on the exchange of shares of Common Stock for Junior Series B Participating Preferred Stock.
​
The tax consequences to you of the Offer to Exchange will depend on your own particular circumstances. You should consult your tax advisor concerning the tax consequences to you (including the application and effect of any state, local or non-U.S. income and other tax laws) of the Offer to Exchange. For a
 
9

Table of Contents
 
more detailed summary of the U.S. federal income tax consequences of the Offer to Exchange, see “U.S. Federal Income Tax Considerations” in this Offer to Exchange.
Q:
What is the impact of the Tax Benefits Preservation Plan on my ownership of the Junior Series B Participating Preferred Stock?
​
A:
Under our Tax Benefits Preservation Plan, any person or group, other than certain exempt or grandfathered persons, together with its affiliates and associates, that acquires ownership of 4.9% or more of the combined value of the Junior Series B Participating Preferred Stock and the Common Stock (or of the then-outstanding shares of Common Stock) without the approval of the Board of Directors may suffer substantial dilution of its ownership interest in the Company. As a result, for any holder of 4.9% or more of the Junior Series B Participating Preferred Stock, aggregate ownership of 4.9% or more of the combined value of the holder’s Junior Series B Participating Preferred Stock and Common Stock could result from an acquisition of Common Stock even if Common Stock ownership is less than 4.9% of then-outstanding shares.
​
Q:
What protections will I have if I decide I do not want to tender my shares?
​
A:
None. If you do not tender your shares of Common Stock in the Exchange Offer, you will continue to hold such shares. Our shares of Common Stock are subordinate to the Junior Series B Participating Preferred Stock in respect of dividends and rights upon liquidation.
​
Q:
Do I have a choice in whether to tender my shares?
​
A:
Yes. Holders of shares of Common Stock are not required to tender their shares pursuant to the Exchange Offer.
​
Q:
How long do I have to decide if I want to tender my shares, or withdraw previously tendered shares?
​
A:
Unless extended or earlier terminated, the Exchange Offer and withdrawal rights expire at one minute following 11:59 P.M. (12:00 midnight), New York City Time, on December 15, 2026. If you hold your shares in street name (i.e., through a broker, dealer or other nominee), you should consult with that firm to see if they have an earlier deadline.
​
Q:
How do I tender my shares of Common Stock?
​
A:
To tender shares of Common Stock, you must deliver a completed Letter of Transmittal and any other documents required by the Letter of Transmittal, together, in the case of certificated shares, with the certificates representing your shares, to the Exchange Agent for the Exchange Offer, not later than the time the Exchange Offer expires. The Letter of Transmittal is enclosed with this Offer to Exchange. If your shares are held in street name (i.e., through a broker, dealer or other nominee), your shares can be tendered by your nominee by book-entry transfer through The Depository Trust Company, or “DTC.” In all cases, tendered shares of Common Stock will be exchanged for Junior Series B Participating Preferred Stock only after timely receipt by the Exchange Agent of such shares (or of a confirmation of a book-entry transfer of such shares as described in “The Exchange Offer — Procedures for Tendering Shares of Common Stock”) and a properly completed and duly executed Letter of Transmittal and any other required documents for such shares.
​
Q:
How do I withdraw previously tendered shares of Common Stock?
​
A:
A stockholder may withdraw shares of Common Stock tendered pursuant to the Exchange Offer at any time prior to the Expiration Date. For a withdrawal of shares of Common Stock to be effective, a written or facsimile transmission notice of withdrawal must be timely received by the Exchange Agent at its address set forth on the back cover of this Offer to Exchange. See “The Exchange Offer — Withdrawal Rights.”
​
​
 
10

Table of Contents
 
Q:
How soon after the Expiration Date will the exchange take place?
​
A:
The exchange is expected to occur promptly following the Expiration Date, but we may not announce the final results of proration or exchange of shares of Common Stock until approximately five trading days after the Expiration Date.
​
Q:
Whom do I call if I have any questions on how to tender my shares of Common Stock or any other questions relating to the Exchange Offer?
​
A:
Questions related to the terms of the Exchange Offer and requests for assistance, as well as for additional copies of this Offer to Exchange or any other documents, may be directed to the Information Agent using the contact information set forth on the back cover of this Offer to Exchange.
​
Q:
Where can I find more information about the Company?
​
A:
For more information, see our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and the other reports and documents we file with the SEC, which are available online at the SEC website (www.sec.gov) and our website (www.redwoodtrust.com), and are also available from us upon request.
​
​
 
11

Table of Contents​
 
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Offer to Exchange and the documents incorporated by reference herein contain forward-looking statements. Forward-looking statements involve numerous risks and uncertainties. Our actual results may differ from our beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements are not historical in nature and can be identified by words such as “anticipate,” “estimate,” “will,” “should,” “expect,” “believe,” “intend,” “seek,” “plan” and similar expressions or their negative forms, or by references to strategy, plans, opportunities, or intentions. These forward-looking statements are subject to risks and uncertainties, including, among other things, those described in this Offer to Exchange and the Annual Report on Form 10-K under the caption “Risk Factors.” Other risks, uncertainties, and factors that could cause actual results to differ materially from those projected are described below and may be described from time to time in reports we file with the SEC, including reports on Forms 10-Q and 8-K. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Important factors, among others, that may affect our actual results include:
•
adverse economic and market conditions — including in housing, real estate, mortgage finance, and broader financial markets;
​
•
changing benchmark interest rates — and the Federal Reserve’s actions and statements;
​
•
federal, state, and local legislative and regulatory developments, and actions by governmental authorities and entities;
​
•
our ability to compete successfully;
​
•
our ability to adapt our business model and strategies;
​
•
strategic business and capital deployment decisions we make;
​
•
our ability to realize the anticipated benefits of our plan to revoke our election to be treated as a REIT for U.S. federal income tax purposes in 2027 and become a taxable C-corporation;
​
•
our ability to utilize our net operating losses and other carryforwards to offset future income tax liabilities;
​
•
our use of financial leverage;
​
•
our exposure to a breach of our cybersecurity or data security;
​
•
the impact of public health events such as pandemics;
​
•
our exposure to credit risk and the timing of credit losses within our portfolio;
​
•
the concentration of the credit risks we are exposed to, including due to the structure of assets we hold and the geographical concentration of real estate underlying assets we own, and our exposure to environmental and climate-related risks;
​
•
the efficacy and expense of our efforts to manage or hedge credit risk, interest rate risk, and other financial and operational risks;
​
•
changes in credit ratings on assets we own and changes in the rating agencies’ credit rating methodologies;
​
•
changes in interest rates or mortgage prepayment rates;
​
•
investment and reinvestment risk;
​
•
asset performance, interest rate volatility, changes in credit spreads, and changes in liquidity in the market for real estate securities and loans;
​
•
our ability to finance the acquisition of real estate-related assets with short-term debt;
​
•
the ability of counterparties to satisfy their obligations to us;
​
 
12

Table of Contents
 
•
we may enter into new lines of business, acquire other companies, or engage in other new strategic initiatives;
​
•
changes in the demand from investors for residential consumer and residential investor mortgages and investments, and our ability to distribute residential consumer and residential investor loans through our whole-loan distribution channels;
​
•
our involvement in loan origination and securitization transactions, the profitability of those transactions, and the risks we are exposed to in engaging in loan origination or securitization transactions;
​
•
foreclosure activity may expose us to risks associated with real estate ownership and operation;
​
•
exposure to claims and litigation, including litigation arising from loan origination and securitization transactions;
​
•
acquisitions or new business initiatives may fail to improve our business and could expose us to new or increased risks;
​
•
whether we have sufficient liquid assets to meet short-term needs;
​
•
changes in our investment, financing, and hedging strategies and new risks we may be exposed to if we expand or reorganize;
​
•
our ability to successfully retain or attract key personnel;
​
•
we are dependent on third-party information systems and third-party service providers;
​
•
our exposure to a disruption of our or a third party’s technology infrastructure and systems;
​
•
our failure to maintain appropriate internal controls over financial reporting and disclosure controls and procedures;
​
•
our risk management efforts may not be effective;
​
•
we could be harmed by misconduct or fraud;
​
•
inadvertent errors, system failures or cybersecurity incidents could disrupt our business;
​
•
the impact on our reputation that could result from our actions or omissions or from those of others;
​
•
accounting rules related to certain of our transactions and asset valuations are highly complex and involve significant judgment and assumptions;
​
•
the future realization of our deferred tax assets is uncertain, and the amount of valuation allowance we may apply against our deferred tax assets may change materially in future periods;
​
•
the impact of changes to U.S. federal income tax laws on the U.S. housing market, mortgage finance markets, and our business;
​
•
regulatory risk related to HEI, including recharacterization or regulation as mortgage loans;
​
•
our failure to comply with applicable laws and regulation, including our ability to obtain or maintain required governmental licenses;
​
•
our ability to maintain our status as a REIT for tax purposes until we consummate our plan to revoke our election to be treated as a REIT for U.S. federal income tax purposes in 2027 and become a taxable C-corporation;
​
•
our ability to raise, manage, and deploy capital;
​
•
limitations imposed on our business due to our REIT status in 2026 and our status as exempt from registration under the Investment Company Act of 1940;
​
•
our Tax Benefits Preservation Plan and/or the provisions in our charter and bylaws and provisions of Maryland law may limit a change in control or deter a takeover;
​
 
13

Table of Contents
 
•
the ability to take action against our directors and officers is limited by our charter and bylaws and provisions of Maryland law and we may indemnify them against certain losses;
​
•
our stock may experience losses, volatility, and poor liquidity, and we may reduce our dividends;
​
•
a limited number of institutional stockholders own a significant percentage of our Common Stock;
​
•
future sales of our stock or other securities by us or our officers and directors may have adverse consequences for investors;
​
•
the change-in-control-related conversion rights of our preferred stock may be detrimental to holders of our Common Stock;
​
•
dividend distributions and the timing and character of such dividends may change;
​
•
payment of dividends in Common Stock could place downward pressure on the market price of our Common Stock;
​
•
our reverse stock split scheduled to become effective on January 4, 2027 could place downward pressure on the market price of our Common Stock;
​
•
actions of activist stockholders could cause us to incur substantial costs and adversely affect our business; and
​
•
other factors not yet identified, including broad market fluctuations.
​
You should consider these factors carefully in evaluating these forward-looking statements and are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Offer to Exchange. It is impossible for us to predict new events or circumstances that may arise in the future or how they may affect us, and we caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity and the development of the industry in which we operate may differ materially from these forward-looking statements. We undertake no obligation to update these forward-looking statements to reflect events or circumstances occurring after the date of this Offer to Exchange. In addition, these forward-looking statements provide our expectations, plans or forecasts of future events and views as of the date of this Offer to Exchange. We anticipate that subsequent events and developments will cause our assessments to change. These forward-looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of this Offer to Exchange.
 
14

Table of Contents​
 
RISK FACTORS
Risks Related to the Junior Series B Participating Preferred Stock
The Junior Series B Participating Preferred Stock is a new issuance, with no stated maturity date, and does not have an established trading market, which may negatively affect its market value and your ability to transfer or sell your shares.
The shares of Junior Series B Participating Preferred Stock are a new issue of securities with no established trading market. In addition, because the Junior Series B Participating Preferred Stock has no stated maturity date, investors seeking liquidity will be limited to selling their shares in the secondary market. We intend to file an application to list the Junior Series B Participating Preferred Stock on the NYSE but there can be no assurance that the NYSE will approve the Junior Series B Participating Preferred Stock for listing. Even if the NYSE approves our application, however, an active trading market on the NYSE for the shares may not develop or, even if it develops, may not last, in which case the trading price of the shares could be adversely affected and your ability to transfer your shares of Junior Series B Participating Preferred Stock will be limited.
The amount you receive if we elect to redeem the Junior Series B Participating Preferred Stock, or upon an involuntary or voluntary liquidation, dissolution or winding up of the Company, may be less than the stated liquidation preference and may not adequately compensate you.
If we elect to redeem the Junior Series B Participating Preferred Stock, including in connection with a Change of Control, or if the Company undergoes an involuntary or voluntary liquidation, dissolution or winding up, holders will be entitled to receive, for each share, a cash payment equal to the Optional Redemption Price. The Optional Redemption Price may be less than the stated $25.00 per share liquidation preference of the Junior Series B Participating Preferred Stock. As a result, the amount you receive in any such event may be less than the stated liquidation preference and may not adequately compensate you.
The Change of Control conversion feature may not adequately compensate you and may make it more difficult for a party to take over our company or discourage a party from taking over our company.
Upon the occurrence of a Change of Control, unless the Company elects to redeem the Junior Series B Participating Preferred Stock pursuant to its terms, all outstanding shares of Junior Series B Participating Preferred Stock will automatically convert into shares of Common Stock (or equivalent value of alternative consideration) based on the five-day VWAP of the Common Stock prior to the date the Change of Control occurred, which may not adequately compensate you. (See “Description of Junior Series B Participating Cumulative Redeemable Preferred Stock — Automatic Conversion.”) Upon such a conversion, the holders will be limited to a maximum number of shares of our Common Stock (or, if applicable, Alternative Conversion Consideration as defined herein) equal to the Share Cap multiplied by the number of shares of Junior Series B Participating Preferred Stock converted, which may result in a holder receiving a value per share of Junior Series B Participating Preferred Stock that is less than the stated $25.00 per share liquidation preference. In addition, the Change of Control conversion feature of the Junior Series B Participating Preferred Stock may have the effect of discouraging a third party from making an acquisition proposal for our company or of delaying, deferring or preventing certain change of control transactions of our company under circumstances that otherwise could provide the holders of our Common Stock and Junior Series B Participating Preferred Stock with the opportunity to realize a premium over the then-current market price or that stockholders may otherwise believe is in their best interests.
The Articles Supplementary establishing the terms of the Junior Series B Participating Preferred Stock will contain restrictions upon ownership and transfer of the Junior Series B Participating Preferred Stock.
The Articles Supplementary establishing the terms of the Junior Series B Participating Preferred Stock will contain restrictions on ownership and transfer of the Junior Series B Participating Preferred Stock. For example, the terms of the Junior Series B Participating Preferred Stock will restrict any person from acquiring actual or constructive ownership of more than 4.9%, in number of shares or value, of the
 
15

Table of Contents
 
outstanding shares of our Junior Series B Participating Preferred Stock, unless certain grandfathering provisions apply. See “Description of Junior Series B Participating Cumulative Redeemable Preferred Stock — Restrictions on Ownership and Transfer” in this Offer to Exchange. You should consider these ownership limitations prior to your exchange of shares of Common Stock for the Junior Series B Participating Preferred Stock. These ownership restrictions could also have anti-takeover effects and could reduce the possibility that a third party will attempt to acquire control of the company, which could adversely affect the market price of the Junior Series B Participating Preferred Stock.
The Junior Series B Participating Preferred Stock ranks junior as to dividend rights and rights upon liquidation to our outstanding Series A Preferred Stock.
We have 2,800,000 issued and outstanding shares of Series A Preferred Stock, which ranks senior to the Junior Series B Participating Preferred Stock as to dividend rights and rights upon our liquidation, dissolution or winding up. The outstanding shares of the senior preferred stock could have the effect of reducing the amounts available to the Junior Series B Participating Preferred Stock upon our liquidation, dissolution or winding up.
We may issue additional shares of Junior Series B Participating Preferred Stock and additional series of preferred stock that rank senior to or on a parity with the Junior Series B Participating Preferred Stock as to dividend rights, rights upon liquidation or voting rights without any vote of holders of the Junior Series B Participating Preferred Stock, which could adversely affect the rights of holders of the Junior Series B Participating Preferred Stock.
We are allowed to issue additional shares of Junior Series B Participating Preferred Stock and additional series of preferred stock that would rank senior to or on a parity with the Junior Series B Participating Preferred Stock as to dividend payments and rights upon our liquidation, dissolution or winding up of our affairs pursuant to our charter and the Articles Supplementary for the Junior Series B Participating Preferred Stock without any vote of the holders of the Junior Series B Participating Preferred Stock. The issuance of additional shares of Junior Series B Participating Preferred Stock and additional series of senior or parity preferred stock could have the effect of reducing the amounts available to the Junior Series B Participating Preferred Stock issued in the Exchange Offer upon our liquidation or dissolution or the winding up of our affairs. It also may reduce dividend payments on the Junior Series B Participating Preferred Stock issued in the Exchange Offer if we do not have sufficient funds to pay dividends on all Junior Series B Participating Preferred Stock outstanding and other classes of stock with equal priority with respect to dividends.
Future issuances and sales of senior or parity preferred stock, or the perception that such issuances and sales could occur, may cause prevailing market prices for the Junior Series B Participating Preferred Stock and our Common Stock to decline, and may adversely affect our ability to raise additional capital in the financial markets at times and prices favorable to us.
There may be future sales or other dilution of our equity, which may adversely affect the market price of the Junior Series B Participating Preferred Stock and the Common Stock.
Future sales or issuances of our Common Stock, including the issuance of shares of our Common Stock upon conversion of the currently outstanding convertible preferred stock and upon exercise of our outstanding warrants would be substantially dilutive to the outstanding shares of Common Stock. We may also issue shares of the Common Stock or securities convertible into the Common Stock in the future. In addition, we periodically raise capital by issuing common stock, preferred stock, or debt securities (including debt securities convertible into common stock), through underwritten public offerings, in at-the-market (“ATM”) offerings, under our direct stock purchase and dividend reinvestment plan, or in private placement transactions. We may receive inquiries regarding equity raising during the Exchange Offer Period. Any such equity issuances may have a dilutive or potentially dilutive effect on our Common Stock. Any dilution or potential dilution may cause our stockholders to sell their shares, which would contribute to a downward movement in the stock price of our Common Stock, which, in turn, could adversely affect the trading price and liquidity of the Junior Series B Participating Preferred Stock.
 
16

Table of Contents
 
Shares of the Junior Series B Participating Preferred Stock are subordinated to existing and future debt.
In the event of our bankruptcy, liquidation, dissolution or winding-up of our affairs, our assets will be available to pay obligations on the Junior Series B Participating Preferred Stock only after all of our indebtedness and other liabilities have been paid. The rights of holders of the Junior Series B Participating Preferred Stock to participate in the distribution of our assets will rank junior to the prior claims of our current and future creditors, and any future series or class of preferred stock we may issue that ranks senior to the Junior Series B Participating Preferred Stock. In addition, the Junior Series B Participating Preferred Stock effectively ranks junior to all existing and future indebtedness and other liabilities of (as well as any preferred equity interests held by others in) our existing subsidiaries and any future subsidiaries. Our subsidiaries are separate legal entities and have no legal obligation to pay any amounts to us in respect of dividends due on the Junior Series B Participating Preferred Stock. If we are forced to liquidate our assets to pay our creditors, we may not have sufficient assets to pay amounts due on any or all of the Junior Series B Participating Preferred Stock then outstanding and any parity securities that we have issued or may issue in the future, in which case, holders of the Junior Series B Participating Preferred Stock will share ratably with holders of such parity securities. We and our subsidiaries have incurred and may in the future incur substantial amounts of debt and other obligations that will rank senior to the Junior Series B Participating Preferred Stock. As of September 30, 2026, we had approximately $29.568 billion of indebtedness and other liabilities ranking senior to the Junior Series B Participating Preferred Stock. Certain of our existing or future debt instruments may restrict the authorization, payment or setting apart of dividends on the Junior Series B Participating Preferred Stock.
Future offerings of debt or senior equity securities may adversely affect the market price of the Junior Series B Participating Preferred Stock. If we decide to issue debt or senior equity securities in the future, it is possible that these securities will be governed by an indenture or other instrument containing covenants restricting our operating flexibility.
Additionally, any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of the Junior Series B Participating Preferred Stock and may result in dilution to owners of the Junior Series B Participating Preferred Stock. We and, indirectly, our stockholders, will bear the cost of issuing and servicing such securities. Because our decision to issue debt or equity securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings. Thus, holders of the Junior Series B Participating Preferred Stock will bear the risk of our future offerings reducing the market price of the Junior Series B Participating Preferred Stock and diluting the value of their holdings in us.
If our Common Stock is delisted, your ability to transfer or sell your shares of the Junior Series B Participating Preferred Stock may be limited and the market value of the Junior Series B Participating Preferred Stock will be materially adversely affected.
Other than in connection with certain change of control transactions, the Junior Series B Participating Preferred Stock does not contain provisions that protect you if our Common Stock is delisted. Since the Junior Series B Participating Preferred Stock has no stated maturity date, you may be forced to hold your shares of the Junior Series B Participating Preferred Stock and receive stated dividends on the stock when, as and if authorized by our Board and declared by us with no assurance as to ever receiving the liquidation preference. In addition, if our Common Stock is delisted, it is likely that the Junior Series B Participating Preferred Stock will be delisted as well. Accordingly, if our Common Stock is delisted, your ability to transfer or sell your shares of the Junior Series B Participating Preferred Stock may be limited and the market value of the Junior Series B Participating Preferred Stock will be materially adversely affected.
We may not have sufficient cash to pay dividends on the Junior Series B Participating Preferred Stock.
We conduct substantially all of our business through our subsidiaries. Accordingly, our ability to pay dividends on the Junior Series B Participating Preferred Stock depends on the earnings and distribution of funds from our subsidiaries. Each of these subsidiaries is a distinct legal entity and, under certain circumstances, legal and contractual restrictions may limit our ability to obtain cash from them.
 
17

Table of Contents
 
Our ability to pay dividends is limited, including by the requirements of Maryland law.
Our dividend distributions are driven by a variety of factors, including, for 2026, the REIT distribution requirements and our REIT taxable income as calculated pursuant to the Code. We generally intend to distribute to our stockholders at least 90% of our REIT taxable income for so long as we are subject to tax as a REIT, although our reported financial results for GAAP purposes may differ materially from our REIT taxable income.
Our ability to pay a dividend at the same rate or similar rates at which we have in the past may be adversely affected by a number of factors, including the risk factors described herein and in our most recent Annual Report on Form 10-K filed with the SEC. These same factors may affect our ability to pay other future dividends. In addition, we may decide to reduce or eliminate our distributions. Any reduction or elimination of our payment of dividend distributions would not only reduce the amount of dividends you would receive as a holder of our Junior Series B Participating Preferred Stock, but could also have the effect of reducing the market price of our Junior Series B Participating Preferred Stock and our ability to raise funds in new securities offerings.
Our ability to pay dividends on or redeem shares of the Junior Series B Participating Preferred Stock is limited by Maryland law. Under applicable Maryland law, a Maryland corporation generally may not make a distribution (including a dividend or redemption) if, after giving effect to the distribution, the corporation would not be able to pay its debts as the debts become due in the usual course of business, or the corporation’s total assets would be less than the sum of its total liabilities plus, unless the corporation’s charter provides otherwise, the amount that would be needed, if the corporation were dissolved at the time of the distribution, to satisfy the preferential rights upon dissolution of stockholders whose preferential rights on dissolution are superior to those receiving the distribution. Accordingly, we generally may not make a distribution on Junior Series B Participating Preferred Stock if, after giving effect to the distribution, we would not be able to pay our debts as they become due in the usual course of business or our total assets would be less than the sum of our total liabilities plus, unless the terms of such class or series provide otherwise, the amount that would be needed to satisfy the preferential rights upon dissolution of the holders of shares of any class or series of preferred stock then outstanding, if any, with preferences senior to those of the Junior Series B Participating Preferred Stock.
Market interest rates and other factors may affect the value of the Junior Series B Participating Preferred Stock.
One of the factors that will influence the prices of the Junior Series B Participating Preferred Stock will be the dividend yield on the Junior Series B Participating Preferred Stock relative to market interest rates. An increase in market interest rates could cause the market prices of the Junior Series B Participating Preferred Stock to go down. The trading prices of the shares of the Junior Series B Participating Preferred Stock will also depend on many other factors, which may change from time to time, including:
•
the market for similar securities;
​
•
government action or regulation;
​
•
general economic conditions or conditions in the financial or real estate markets; and
​
•
our financial condition, performance and prospects.
​
In addition, over the last several years, prices of equity securities in the U.S. trading markets have been experiencing extreme price fluctuations, and the market price of our Common Stock has also fluctuated significantly during this period. As a result of these and other factors, holders who receive the Junior Series B Participating Preferred Stock in this Exchange Offer may experience a decrease, which could be substantial and rapid, in the market price of the Junior Series B Participating Preferred Stock, including decreases unrelated to our operating performance or prospects. Likewise, in the event that the Junior Series B Participating Preferred Stock becomes convertible upon a Change of Control and is converted into our Common Stock, holders of our Common Stock issued on conversion may experience a similar decrease, which also could be substantial and rapid, in the market price of our Common Stock.
 
18

Table of Contents
 
Risks Related to the Exchange Offer
The Exchange Offer is subject to certain contingencies and may not be completed.
The Exchange Offer is subject to certain contingencies that are not within the control of the Company. The Exchange Offer is conditioned on the closing conditions described under “The Exchange Offer —  Conditions to the Exchange Offer.” We will not be required, but we reserve the right, to waive any of the conditions of the Exchange Offer (to the extent permitted by applicable law) and accept for exchange any shares of Common Stock tendered (or, alternatively, we may elect to terminate the Exchange Offer) if any of the conditions of the Exchange Offer as described under “The Exchange Offer — Conditions to the Exchange Offer” remain unsatisfied. For instance, the Exchange Offer requires the valid tender (without valid withdrawal) of at least 8,680,000 shares of Common Stock prior to the Expiration Date. There can be no assurance that all required conditions, consents, or regulatory approvals will be obtained or achieved in a timely manner. Moreover, the Exchange Offer may be modified or withdrawn in certain circumstances subject to the discretion of the Company’s Board of Directors. See “The Exchange Offer — Conditions to the Exchange Offer.”
The successful completion of the Exchange Offer will result in a diminished public float for our Common Stock, which could adversely affect the liquidity and market value of our Common Stock and create uncertainty as to whether our Common Stock would remain eligible for listing on the NYSE or any other national securities exchange.
Upon the consummation of the Exchange Offer, there will be fewer shares of our Common Stock held by our unaffiliated stockholders, and there will therefore likely be fewer transactions in our Common Stock. If the Common Stock does not meet the NYSE’s continued listing requirements, our Common Stock may be delisted, and the Common Stock may not satisfy the listing requirements of any other national securities exchange. We will use our reasonable best efforts to maintain the listing of our Common Stock on the NYSE; if our Common Stock is delisted from the NYSE, we will use our reasonable best efforts to have our Common Stock listed on another national securities exchange; and, in the event we are unable to cause the Common Stock to be listed on another national securities exchange after it is delisted from the NYSE, we will use our reasonable best efforts to cause a market to be made for the Common Stock. A lack of an active trading market may have an adverse effect on the trading price of our Common Stock.
If you do not tender your shares of Common Stock in the Exchange Offer, those shares will be subordinate in right of payment and distribution upon liquidation to the Junior Series B Participating Preferred Stock.
If you do not tender your shares of Common Stock in the Exchange Offer, you will continue to hold such shares. Additionally, unlike the Common Stock, the Junior Series B Participating Preferred Stock has a cumulative dividend rate of 12.00%, and the Common Stock is junior to the Junior Series B Participating Preferred Stock in respect of distributions upon liquidation.
We have not obtained a third-party determination that the Exchange Offer is fair to holders of Common Stock.
Neither we, our Board, the Information Agent, the Exchange Agent, nor any affiliate of any of the foregoing nor any other person is making any recommendation as to whether or not you should tender your shares of Common Stock in the Exchange Offer. We have not authorized any person to make such a recommendation. We have not retained, and do not intend to retain, any unaffiliated representative to act solely on behalf of the holders of Common Stock for purposes of negotiating the Exchange Offer or preparing a report concerning the fairness of the Exchange Offer. We cannot assure holders of shares of Common Stock that the value of the Junior Series B Participating Preferred Stock received in the Exchange Offer will in the future equal or exceed the value of the shares of Common Stock tendered and we do not take a position as to whether you should participate in the Exchange Offer. If you tender your shares of Common Stock, you may or may not receive more than or as much value as you may receive if you choose to keep such shares of Common Stock. You must make your own independent decision regarding your participation in the Exchange Offer.
 
19

Table of Contents
 
All shares of Common Stock that remain outstanding after the Exchange Offer will rank lower in priority to the Junior Series B Participating Preferred Stock with respect to distributions in the event of a voluntary or involuntary liquidation, dissolution or winding up.
In any voluntary or involuntary liquidation, dissolution or winding up of the Company, shares of Common Stock would rank below all of the shares of the Junior Series B Participating Preferred Stock issued in the Exchange Offer. As a result, holders of Common Stock will not be entitled to receive any payment or other distribution of assets upon such liquidation, dissolution or winding up until our obligations to the holders of Junior Series B Participating Preferred Stock have been satisfied.
The tax consequences of the Exchange Offer are complex and will vary depending on your particular facts and circumstances.
The U.S. federal income tax consequences to you of participating in the Exchange Offer are complex and will vary depending on certain facts and circumstances. We intend to treat the exchange of shares of Common Stock for shares of Junior Series B Participating Preferred Stock as a “recapitalization” pursuant to Section 368(a)(1)(E) of the Code pursuant to which you should not recognize any gain or loss on the exchange of your Common Stock for shares of Junior Series B Participating Preferred Stock (other than with respect to any cash received in lieu of a fractional share of our Junior Series B Participating Preferred Stock). However, alternative characterizations are possible by the IRS or a court, including ones that would require you to recognize taxable income on the exchange of your Common Stock for shares of Junior Series B Participating Preferred Stock. See “U.S. Federal Income Tax Considerations.”
Risks Related to our Business
For a discussion of the risks associated with our business, please see the discussion of risks related to our business under the heading “Risk Factors” in our Annual Report.
We may fail to realize the anticipated benefits of our plan to revoke our election to be treated as a REIT for U.S. federal income tax purposes in 2027 and become a taxable C-corporation, or those benefits may take longer to realize than expected, if at all, or may not offset the costs of revoking our REIT election and becoming a taxable C-corporation.
We believe that our plan to revoke our election to be treated as a REIT for U.S. federal income tax purposes in 2027 and become a taxable C-corporation will, among other things, allow us greater flexibility to retain and reinvest our earnings in our mortgage banking platforms, create a pathway to a more efficient financing structure and a lower cost of capital, and allow for more effective utilization of our existing tax assets and, to the extent our tax assets are available to offset taxable income, reduce our tax liabilities in the near term. However, there can be no assurance that we will realize any of these anticipated benefits, in whole or in part, or on the timeline we expect.
Retention and reinvestment of earnings.   We believe that our plan to terminate our REIT election in 2027 and become a taxable C-corporation will, among other things, provide us with greater flexibility to use our free cash flows, among other things, to invest in our mortgage banking platforms and reduce our outstanding debt and debt leverage, as we will no longer be required to operate in compliance with the requirements for taxation as a REIT, including the requirement to distribute at least 90% of our taxable income to our stockholders. However, we may not generate sufficient earnings to retain at the levels we anticipate, which may reduce, or eliminate, the anticipated benefits of our plan to transition from a REIT to a taxable C-corporation. Even if we are able to retain greater earnings as a C-corporation than as a REIT, we may not be able to deploy them in platforms, investments or initiatives that produce the returns we expect, or at all, and we may not be able to reduce our outstanding debt and debt leverage as quickly or as much as we desire.
Access to and cost of capital.   We believe our planned transition to C-corporation status may improve our access to institutional unsecured debt and equity capital and, over time, all other factors being equal, result in a structurally lower cost of capital. Our cost of capital and access to capital depend on many factors, however, many of which are beyond our control. Investors who held our Common Stock because of our
 
20

Table of Contents
 
REIT status or dividend yield may decide to sell their shares. We may also be unable to attract new investors in sufficient numbers, or on the timeline we expect, to broaden our investor base. There can be no assurance that our access to capital will improve or that our cost of capital will decline, or that any such improvement will happen within the timeframe we expect.
Tax assets.   A significant part of the anticipated benefit of our planned transition to C-corporation status depends on our ability to use our existing tax assets, including our net operating loss carryforwards (“NOLs”) and other deferred tax assets, to offset future taxable income. For additional information, see “Our ability to utilize our NOLs and other carryforwards may be limited” and “Our Tax Benefits Preservation Plan may discourage investment in our Common Stock or other securities convertible or exercisable into our Common Stock, limit our access to capital, and have anti-takeover effects” below.
Moreover, there can be no assurance that the anticipated benefits of our planned transition to C-corporation status will offset its costs, which could be greater than we expect. Following such transition, we will not be allowed a deduction for dividends paid to our stockholders in computing our taxable income and will be subject to U.S. federal and state income tax on our taxable income at corporate tax rates. This could impair our ability to satisfy our financial obligations and negatively impact the price of our Common Stock and other securities. This treatment could also reduce our net earnings available for investment or distribution to our stockholders because of the additional tax liability to us. Further, federal and state income tax rates could increase in the future, exacerbating these risks. We also will be disqualified from electing REIT status under the Code through December 31, 2031. If we fail to achieve the anticipated benefits of our planned transition to C-corporation status at all or in a timely manner, or if any benefits we realize do not offset its costs, our business, financial condition, results of operations and the market price of our Common Stock and other securities could be negatively affected.
Our ability to utilize our NOLs and other carryforwards may be limited.
Under the Code, a corporation is generally allowed a deduction for NOLs carried over from prior taxable years, subject to certain limitations. As of September 30, 2026, we had approximately $304 million of federal NOLs, of which $29 million expire in 2029 and $275 million can be carried forward indefinitely. Our NOL carryforwards are subject to adjustment on audit by the IRS and the respective state taxing authorities. Additionally, certain of our NOL carryforwards may expire before we can generate sufficient taxable income to use them.
Our ability to use our NOLs and other carryforwards depends on the amount of taxable income generated in future periods. There can be no assurance that an additional valuation allowance on our net deferred tax assets will not be required should our financial performance be negatively impacted in the future. Such valuation allowance could be material and would reduce our earnings and book value. In addition, the use of NOLs and other carryforwards to offset taxable income is subject to various limitations, which could limit our ability to utilize these tax attributes to reduce our taxes even if we generate sufficient taxable income.
A corporation’s ability to deduct its federal NOL carryforwards and to utilize certain other available tax attributes can be substantially constrained under the general annual limitation rules of Section 382 of the Code (“Section 382”) if it undergoes an “ownership change” as defined in Section 382 (generally where cumulative stock ownership changes among material stockholders exceed 50% during a rolling three-year period). An “ownership change” may severely limit or effectively eliminate our ability to utilize our NOL carryforwards and other tax attributes. Because the determination of whether an “ownership change” has occurred for purposes of Section 382 depends in part on changes in the ownership of our stock that are outside of our control, including purchases and sales of our Common Stock by existing and new stockholders, there can be no assurance that we will not experience an “ownership change” in the future. In addition, there is no assurance that the IRS will agree with our determination, now or in the future, of whether an “ownership change” has occurred.
Our efforts to preserve our NOLs and other tax attributes may also constrain our ability to access the capital markets and otherwise manage our capital structure. Issuances of our capital stock, including in connection with capital-raising transactions, acquisitions, or the conversion or exchange of our convertible
 
21

Table of Contents
 
or exchangeable securities, and repurchases of our capital stock can each contribute to an “ownership change” under Section 382. Accordingly, in order to reduce the likelihood of an “ownership change”, we may be limited in our ability to issue capital stock to raise capital, or to repurchase our capital stock, at times when we believe that doing so would otherwise be in our best interests and those of our stockholders. Any such limitation could reduce our financial flexibility, increase our cost of capital, or cause us to forgo attractive investment or capital management opportunities, any of which could adversely affect our business, financial condition, liquidity, and results of operations.
On November 3, 2026, our Board of Directors adopted the Tax Benefits Preservation Plan in order to preserve our ability to use our NOLs and certain other tax attributes to reduce potential future U.S. federal income tax obligations. The Tax Benefits Preservation Plan is designed to reduce the likelihood that we experience an “ownership change” by deterring certain acquisitions of our Common Stock. There is no assurance, however, that the deterrent mechanism will be effective, and acquisitions of our Common Stock, alone or in combination with other changes in the ownership of our stock, may still result in an “ownership change” under Section 382. For example, the Tax Benefits Preservation Plan may not deter a person who is willing to accept the dilution that would result from becoming an “acquiring person” thereunder, and the Tax Benefits Preservation Plan does not prevent all changes in ownership that are taken into account for purposes of Section 382. In addition, our Board of Directors may exempt persons from the Tax Benefits Preservation Plan’s restrictions in certain circumstances, even if doing so could negatively affect our tax attributes. The Tax Benefits Preservation Plan may also adversely affect the marketability of our Common Stock and have anti-takeover effects. For a discussion of these and other risks associated with the Tax Benefits Preservation Plan, see “Our Tax Benefits Preservation Plan may discourage investment in our Common Stock, or other securities convertible or exercisable into our Common Stock, limit our access to capital, and have anti-takeover effects” below and “The future realization of our deferred tax assets is uncertain, and the amount of valuation allowance we may apply against our deferred tax assets may change materially in future periods” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025.
Our Tax Benefits Preservation Plan may discourage investment in our Common Stock or other securities convertible or exercisable into our Common Stock, limit our access to capital, and have anti-takeover effects.
Under our Tax Benefits Preservation Plan, any person or group, other than certain exempt persons and certain grandfathered persons, that together with its affiliates and associates acquires beneficial ownership of 4.9% or more of the then-outstanding shares of our Common Stock without the approval of our Board of Directors would suffer substantial dilution of its ownership interest in us. The Tax Benefits Preservation Plan may discourage or limit existing or potential investors from acquiring our Common Stock or additional shares of our Common Stock, or other of our securities convertible or exercisable into our Common Stock, including institutional investors who might otherwise seek to acquire positions at or above the 4.9% threshold. The resulting reduction in demand could adversely affect the marketability and liquidity of our Common Stock or other securities and, in turn, their respective market prices. In addition, by reducing the pool of investors willing to acquire significant positions in our Common Stock, the Tax Benefits Preservation Plan may limit our ability to raise capital through the issuance of equity or other equity-linked securities on favorable terms, or at all.
Although the Tax Benefits Preservation Plan was adopted to preserve our tax attributes, it may have an anti-takeover effect because an “acquiring person” thereunder may be diluted upon the occurrence of a triggering event. Accordingly, the Tax Benefits Preservation Plan may complicate or discourage a merger, tender offer, proxy contest, accumulation of a substantial block of our Common Stock, or assumption of control by a substantial holder of our securities, even if such a transaction might involve a premium price for our Common Stock or otherwise be in the best interests of our stockholders. The Tax Benefits Preservation Plan may therefore deter transactions that some or all of our stockholders might consider beneficial. These effects may be in addition to those of the ownership limits contained in our charter. See “Provisions in our charter and bylaws and provisions of Maryland law may limit a change in control or deter a takeover that might otherwise result in a premium price being paid to our shareholders for their shares in Redwood” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025.
 
22

Table of Contents
 
The Tax Benefits Preservation Plan gives our Board of Directors significant discretion to consent to transactions (e.g., a merger or other business combination, or an acquisition of a large interest in our stock) and to exempt persons from the Tax Benefits Preservation Plan’s restrictions. The Board may grant an exemption even if doing so would affect our tax attributes, if it determines that the exemption is in our best interests. As a result, the Tax Benefits Preservation Plan should not interfere with any such transaction that our Board of Directors approves. However, because an acquirer would generally need to negotiate with, and obtain the approval of, our Board of Directors, this may deter or delay transactions that stockholders might otherwise favor. Also, our Board of Directors’ exercise of this discretion may not reflect the views of all of our stockholders. Any exemption it grants could affect our tax attributes or increase the likelihood of an ownership change under Section 382.
The Reverse Stock Split we announced on November 3, 2026 may not achieve its intended results and could adversely affect the market price, liquidity and marketability of our Common Stock.
On November 3, 2026, our Board of Directors unanimously approved a one-for-five Reverse Stock Split of our outstanding Common Stock, which is scheduled to take effect at market open on January 4, 2027. The Reverse Stock Split is intended to have several results, including to enhance the marketability of the Company’s Common Stock and broaden the Company’s appeal to investors who do not trade in lower-priced securities. We cannot assure you, however, that the Reverse Stock Split will achieve these or any other intended results. In particular, we cannot assure you that, following the effective date of the Reverse Stock Split, the market price of our Common Stock will increase in proportion to the Reverse Stock Split ratio, or that any increase will be sustained. The market price of our Common Stock may also decline for reasons unrelated to the Reverse Stock Split, including our future performance. Any such decline may be greater, in absolute terms and as a percentage of our market capitalization, than it would have been without the Reverse Stock Split.
With fewer shares outstanding after the effective date of the Reverse Stock Split, our Common Stock may become less liquid and more volatile. More stockholders may also hold “odd lots” of fewer than 100 shares, which may be harder to sell and generally carry higher brokerage commissions and other transaction costs. For these and other reasons, the Reverse Stock Split may not improve the liquidity or marketability of our Common Stock. We cannot assure you that it will attract investors who do not trade in lower-priced securities, make our Common Stock more attractive to investors generally, or facilitate future capital raising. Reverse stock splits by other companies have had mixed results, in part because some investors view them negatively. Any negative market perception of the Reverse Stock Split could depress the market price of our Common Stock.
Actions of activist stockholders could divert management’s attention and resources, cause us to incur substantial costs and adversely affect our business.
While we value constructive feedback from our investors and regularly engage in dialogue with them on various matters, we may nonetheless be subject to actions or proposals from activist stockholders. Activist stockholders may from time to time engage in proxy solicitations, advance stockholder proposals, or otherwise seek to effect changes relating to our business strategies, including, without limitation, by seeking to acquire control of the Company (or by encouraging others to do so), by seeking a sale of control of the Company (or by seeking a sale of a division of the Company), or by seeking changes to the manner in which we structure or operate our business. For example, an open letter was published in September 2026 by an individual stating that he is a significant stockholder in the Company and, among other things, urging our Board of Directors to explore a sale of the Company. Responding to actions by activist stockholders could be costly and time-consuming, disrupt our business and operations, and divert the attention of our Board of Directors and senior management from the pursuit of our business strategies. Activist stockholder actions may also interfere with our ability to execute our strategic plans. Perceived uncertainties as to our future direction, strategy or leadership created as a consequence of activist stockholders’ communications or initiatives may result in the loss of potential business opportunities, harm our ability to raise equity or debt capital, inhibit our ability to attract new investors, business partners, or employees (or negatively impact our relationship with current investors, business partners, or employees), or negatively impact the value of our capital stock (or result in increased volatility in the trading price of our capital stock). In addition, we have
 
23

Table of Contents
 
retained and may in the future retain the services of various professionals to advise us on activist stockholder matters, including legal, financial, strategic and communication advisors, the costs of which may negatively impact our financial results. The actions of activist stockholders may also cause significant fluctuations in our stock price based on temporary or speculative market perceptions or other factors that do not necessarily reflect the underlying fundamentals of our business. We cannot predict the outcome or timing of any matters relating to actions by activist stockholders or the ultimate impact that such matters may have on the Company.
 
24

Table of Contents​
 
THE EXCHANGE OFFER
General
We are making the Exchange Offer for up to 17,360,000 shares of outstanding Common Stock. Upon the terms and subject to the conditions set forth in this Offer to Exchange and in the Letter of Transmittal, we will accept for exchange any shares of Common Stock that are validly tendered and are not withdrawn prior to the expiration of the Exchange Offer. The Exchange Offer will expire at one minute following 11:59 P.M. (12:00 midnight), New York City time, on December 15, 2026, unless extended or earlier terminated by us.
Consideration to be Received, Subject to Proration
For Each:
​ ​
Consideration to be Received:
​
7.58 shares of Common Stock ​ ​ 1 share of Junior Series B Participating Preferred Stock ​
We will issue 1 share of Junior Series B Participating Preferred Stock in exchange for each 7.58 shares of validly tendered Common Stock promptly after the Expiration Date. Shares of Common Stock may only be exchanged for whole shares of Junior Series B Participating Preferred Stock. In lieu of issuing fractional shares of Junior Series B Participating Preferred Stock to which any holder of shares of Common Stock would otherwise have been entitled, we will round down the number of shares of Junior Series B Participating Preferred Stock to which such holder is entitled, after aggregating all fractions, to the nearest whole number of shares of Junior Series B Participating Preferred Stock, and the amount of consideration that would otherwise have been represented by such fractional share of Junior Series B Participating Preferred Stock will be paid in cash to the tendering stockholders in an amount equal to the corresponding liquidation preference of such fractional share.
A holder may tender as few or as many shares of Common Stock as the holder elects. If more than 17,360,000 shares of Common Stock are validly tendered prior to the Expiration Date, and not validly withdrawn, we will, upon the terms and subject to the conditions of the Offer to Exchange, exchange 17,360,000 shares on a pro rata basis (with adjustments to avoid exchanges of fractional shares) based upon the number of shares of Common Stock validly tendered by the Expiration Date and not validly withdrawn. If proration of tendered shares is required, because of the difficulty of determining the precise number of shares of Common Stock validly tendered and not withdrawn, we do not expect to announce the final results of proration or exchange any shares until approximately five trading days after the Expiration Date. All shares of Common Stock not accepted for exchange will be returned to the stockholder or, in the case of tendered shares of Common Stock delivered by book-entry transfer, credited to the account at the book-entry transfer facility from which the transfer had previously been made, promptly after the expiration or termination of the Exchange Offer in each case, in accordance with the procedure described in the section entitled “— Acceptance of Shares of Common Stock for Exchange and Delivery of Junior Series B Participating Preferred Stock.”
This Offer to Exchange is being sent to all beneficial holders of shares of Common Stock. Shares of Common Stock tendered but not accepted because they were not validly tendered will remain outstanding upon completion of the Exchange Offer. Any tendered shares of Common Stock not accepted for exchange because of an invalid tender, the occurrence of other events set forth in this Offer to Exchange or otherwise, will promptly be returned, without expense, to the tendering stockholder after the Expiration Date. Our obligation to accept shares of Common Stock tendered pursuant to the Exchange Offer is limited by the conditions listed below under “— Conditions to the Exchange Offer.” Shares of Common Stock that are not exchanged in the Exchange Offer will remain outstanding and will be entitled to all rights and benefits their holders have under our charter and bylaws and applicable law.
 
25

Table of Contents
 
Procedures for Tendering Shares of Common Stock
General
In order to receive shares of Junior Series B Participating Preferred Stock in exchange for your shares of Common Stock, you must validly tender your shares of Common Stock, and not withdraw them, prior to the Expiration Date.
If you hold your shares of Common Stock in the name of a bank, broker, custodian or other nominee as a beneficial owner, you must follow the instructions provided by your bank, broker, custodian or other nominee to validly tender your shares of Common Stock in this Exchange Offer.
Should you have any questions as to the procedures for tendering your shares, please call your bank, broker, custodian or other nominee, or call our Information Agent at its telephone number set forth on the back cover of this Offer to Exchange.
In order for a bank, broker, custodian or other nominee to validly tender your shares of Common Stock in the Exchange Offer, a bank, broker, custodian or other nominee must deliver to the Exchange Agent:
•
a message in which you acknowledge and agree to, and agree to be bound by, the terms of the Letter of Transmittal and that we may enforce such agreement against you; and
​
•
a timely confirmation of book-entry transfer of your shares of Common Stock into the Exchange Agent’s account, by which transfer you will be deemed to have given the applicable messages above.
​
You are urged to instruct your bank, broker, custodian or other nominee at least five business days prior to the Expiration Date in order to allow adequate processing time for your instruction. For further information, contact the Information Agent at its telephone number and address set forth on the back cover page of this document or consult your bank, broker, custodian or other nominee for assistance.
We are not providing for guaranteed delivery procedures and therefore you must allow sufficient time for the necessary tender procedures to be completed during normal business hours of DTC prior to the Expiration Date. Tenders not received by the Exchange Agent on or prior to the Expiration Date will be disregarded and of no effect.
Delivery of shares of Common Stock and the method of delivery of all other required documents is at your election and risk and, except as otherwise provided in the Letter of Transmittal, delivery will be deemed made only when actually received by the Exchange Agent. If delivery of any document is by mail, we suggest that you use properly insured, registered mail, with a return receipt requested, and that the mailing be made sufficiently in advance of the Expiration Date to permit delivery to the Exchange Agent prior to the Expiration Date.
Tendering of Shares of Common Stock Through DTC
Shares of Common Stock in book-entry form must be tendered through DTC. The Exchange Agent, promptly after the date of this Offer to Exchange (to the extent such arrangements have not been previously made), will establish and maintain an account with respect to shares of Common Stock at DTC, and any financial institution that is a DTC participant and whose name appears on a security position listing as the owner of shares of Common Stock may make book-entry delivery of such shares of Common Stock by causing DTC to transfer such shares of Common Stock into the Exchange Agent’s account in accordance with DTC’s procedures for such transfer.
To participate in the Exchange Offer, a DTC participant must:
•
comply with the automated tender offer program procedures of DTC described below; or
​
•
(1) complete, sign and date the Letter of Transmittal, or a facsimile of the Letter of Transmittal; (2) have the signature on the Letter of Transmittal guaranteed if the Letter of Transmittal so requires; and (3) mail or deliver the Letter of Transmittal or facsimile to the Exchange Agent prior to the Expiration Date.
​
 
26

Table of Contents
 
In addition, for the tender of shares of Common Stock to be valid, either:
•
the Exchange Agent must receive, prior to the Expiration Date, a properly transmitted Agent’s Message (as defined below); or
​
•
the Exchange Agent must receive, prior to the Expiration Date, a timely confirmation of book-entry transfer of tendered shares of Common Stock into the Exchange Agent’s account at DTC according to DTC’s procedure for book-entry transfer and the Letter of Transmittal and other documents required by the Letter of Transmittal.
​
If shares of Common Stock are tendered by delivery of a Letter of Transmittal, to be validly tendered, the Exchange Agent must receive any physical delivery of the Letter of Transmittal and other required documents at its address indicated on the back cover of this Offer to Exchange and the front cover of the Letter of Transmittal prior to the Expiration Date.
Subject to and effective upon the acceptance for exchange of, and issuance of Junior Series B Participating Preferred Stock for, shares of Common Stock tendered thereby, by executing and delivering the Letter of Transmittal, or being deemed to have done so as part of your electronic submission of your tender through DTC, you agree to be bound by the terms of the Letter of Transmittal, by which, among other things, you (1) irrevocably tender, sell, assign and transfer to or upon our order all right, title and interest in and to all the shares of Common Stock tendered thereby and (2) irrevocably appoint the Company as your true and lawful agent and attorney-in-fact, with full power coupled with an interest, to:
•
transfer ownership of the shares of Common Stock on the account books maintained by DTC, together with all accompanying evidences of transfer and authenticity, to or upon our order;
​
•
present the shares of Common Stock for transfer on the relevant security register; and
​
•
receive all benefits or otherwise exercise all rights of beneficial ownership of the shares of Common Stock, all in accordance with the terms of the Exchange Offer.
​
The method of delivery of the Letter of Transmittal and all other required documents to the Exchange Agent is at your election and risk. Rather than mail these items, if you desire to tender shares of Common Stock, we recommend that you use an overnight delivery service. In all cases where you desire to tender shares of Common Stock, you should allow sufficient time to assure delivery to the Exchange Agent before the Expiration Date. You should not send any Letter of Transmittal to us.
Tendering through DTC’s ATOP
The Exchange Agent and DTC have confirmed that any financial institution that is a participant in DTC’s system may use DTC’s automated tender offer program (“ATOP”) to tender shares of Common Stock in the Exchange Offer. DTC participants may, instead of physically completing and signing the Letter of Transmittal and delivering it to the Exchange Agent, transmit an acceptance of the Exchange Offer electronically. DTC participants may do so by causing DTC to transfer the shares of Common Stock to the Exchange Agent in accordance with its procedures for transfer. DTC will then send an Agent’s Message to the Exchange Agent.
The term “Agent’s Message” means a message transmitted by DTC, received by the Exchange Agent and forming part of the book-entry confirmation, to the effect that:
•
DTC has received an express acknowledgment from a DTC participant that it is tendering shares of Common Stock that are the subject of such book-entry confirmation;
​
•
such DTC participant has received and agrees to be bound by the terms of the Letter of Transmittal; and
​
•
the Letter of Transmittal may be enforced against such DTC participant.
​
Delivery of the Agent’s Message by DTC will satisfy the terms of the Exchange Offer in lieu of execution and delivery of the Letter of Transmittal by the DTC participant identified in the Agent’s Message. Accordingly, the Letter of Transmittal need not be completed by a holder tendering through ATOP.
 
27

Table of Contents
 
Signature Guarantees
Signatures on the Letter of Transmittal must be guaranteed by a firm that is a participant in the Security Transfer Agents Medallion Program or the Stock Exchange Medallion Program or is otherwise an “eligible guarantor institution” as that term is defined in Rule 17Ad-15 under the Exchange Act (generally a member of a registered national securities exchange, a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”) or a commercial bank or trust company having an office in the United States) (an “Eligible Institution”), unless (i) such Letter of Transmittal is signed by the registered holder of the shares of Common Stock tendered therewith and the shares of Junior Series B Participating Preferred Stock issued in exchange for shares of Common Stock are to be issued in the name of and delivered to, or if any shares of Common Stock not accepted for exchange are to be returned to, such holder, or (ii) such shares of Common Stock are tendered for the account of an Eligible Institution.
Determination of Validity
All questions as to the validity, form, eligibility (including time of receipt) and acceptance for exchange of any tendered shares of Common Stock pursuant to any of the procedures described above, and the form and validity (including time of receipt of notices of withdrawal) of all documents will be determined by us in our sole discretion, which determination will be final and binding. Alternative, conditional or contingent tenders will not be considered valid. We reserve the absolute right to reject any or all tenders of any shares of Common Stock we determine not to be in proper form, or if the acceptance of, or exchange of, such shares of Common Stock may, in the opinion of our counsel, be unlawful. We also reserve the right to waive any conditions to the Exchange Offer that we are legally permitted to waive. A waiver of any defect or irregularity with respect to one tender of shares of Common Stock shall not constitute a waiver of the same or any other defect or irregularity with respect to any other tender of shares of Common Stock except to the extent we may otherwise provide. Our interpretation of the terms and conditions of the Exchange Offer will be final and binding.
Your tender will not be deemed to have been validly made until all defects or irregularities in your tender have been cured or waived. None of us, the Exchange Agent, the Information Agent or any other person or entity is under any duty to give notification to you or any other person of any defects or irregularities in any tender or withdrawal of any shares of Common Stock nor will we, the Exchange Agent, or the Information Agent incur any liability for any failure to give any such notification. Please send all materials to the Exchange Agent and not to us or the Information Agent.
The closing sale price for the shares of Common Stock on the NYSE on November 16, 2026, the last full trading day before the announcement of the commencement of the Exchange Offer, was $2.88.
Stockholders also can specify the order in which we will exchange shares of Common Stock tendered in the Exchange Offer in the event that, as a result of the proration provisions or otherwise, we exchange some but not all of the tendered shares of Common Stock pursuant to the Exchange Offer. In the event a stockholder does not designate the order and fewer than all shares of Common Stock are exchanged due to proration or otherwise, the Exchange Agent will select the order of shares of Common Stock exchanged.
Conditions to the Exchange Offer
Notwithstanding any other provisions of this Offer to Exchange, our obligation to accept tendered shares of Common Stock and (subject to any applicable rules and regulations of the SEC, including Rule 14e-1(c) under the Exchange Act) provide shares of Junior Series B Participating Preferred Stock in exchange therefor, is subject to the following conditions:
•
the valid tender (without valid withdrawal) of at least 8,680,000 shares of Common Stock prior to the Expiration Date (the “Minimum Tender Condition”);
​
•
the closing price of our Common Stock on the NYSE shall not be, on any business day prior to (and including the date of) the Expiration Date, more than 10% below the closing price of our Common Stock on November 16, 2026;
​
 
28

Table of Contents
 
•
the Dow Jones Industrial Average, the New York Stock Exchange Composite Index, the NASDAQ Composite Index or the S&P 500 Composite Index shall not close on any business day prior to (and including the date of) the Expiration Date more than 10% below its respective close on November 16, 2026;
​
•
no applicable law and no permanent injunction or other judgment, order or decree shall have been entered, enacted, promulgated, enforced or issued by any court or other governmental entity of competent jurisdiction in the United States or any material foreign jurisdiction that remains in effect which has the effect of prohibiting the consummation of the Exchange Offer;
​
•
there will not be existing any temporary restraining order, preliminary injunction, or any pending or threatened suit, action or proceeding by any governmental entity that challenges or seeks to enjoin the Exchange Offer;
​
•
there will not have occurred any change, effect, occurrence, state of facts or development that is or is reasonably likely to be material and adverse to the financial condition, assets, liabilities, business or results of operations of the Company and its subsidiaries taken as a whole;
​
•
there shall not have been any change or development that in our reasonable judgment materially reduces the anticipated benefits to us of the Exchange Offer or that has had, or could reasonably be expected to have, a material adverse effect on us, our business, condition (financial or otherwise) or prospects; or
​
•
we determine that the consummation of the Exchange Offer and the exchange of shares of Common Stock for shares of Junior Series B Participating Preferred Stock is reasonably likely to cause the Common Stock to be subject to delisting from the NYSE.
​
In addition, our obligation to issue the Junior Series B Participating Preferred Stock is conditioned upon our acceptance of shares of Common Stock pursuant to the Exchange Offer.
The foregoing conditions are for our benefit and may be asserted by us or may be waived by us, including any action or inaction by us giving rise to any condition, in whole or in part, at any time and from time to time, in our sole discretion. In addition, we may terminate the Exchange Offer if any condition is not satisfied at or prior to the Expiration Date. Under the Exchange Offer, if any of these events occur, subject to the termination rights described above, we may (i) return shares of Common Stock tendered thereunder to you, (ii) extend the Exchange Offer, subject to the withdrawal rights described in “— Withdrawal Rights” herein, and retain all shares of Common Stock tendered thereunder until the expiration of such extended offer or (iii) amend the Exchange Offer in any respect by giving oral or written notice of such amendment to the Exchange Agent and making public disclosure of such amendment to the extent required by law.
We have not made a decision as to what circumstances would lead us to waive any such condition, and any such waiver would depend on circumstances prevailing at the time of such waiver. Although we have no present plans or arrangements to do so, we reserve the right to amend, at any time, the terms of the Exchange Offer. We will give holders of shares of Common Stock notice of such amendments as may be required by applicable law.
Acceptance of Shares of Common Stock for Exchange and Delivery of Junior Series B Participating Preferred Stock
If the conditions to the Exchange Offer are satisfied, or if we waive all of the conditions that have not been satisfied, we will accept tendered shares of Common Stock at the Expiration Date and after we receive validly completed and duly executed Letters of Transmittal or Agent’s Messages (as defined in “— Procedures for Tendering Shares of Common Stock — Tendering of Shares of Common Stock Through DTC” above) with respect to any and all of the shares of Common Stock validly tendered and not validly withdrawn for exchange at such time, by notifying the Exchange Agent of our acceptance. The notice may be oral if we promptly confirm it in writing.
We expressly reserve the right, in our sole discretion, to delay acceptance for exchange of shares of Common Stock validly tendered and not validly withdrawn under the Exchange Offer (subject to Rule 14e-1(c) under the Exchange Act, which requires that we issue shares of Junior Series B Participating
 
29

Table of Contents
 
Preferred Stock or return the shares of Common Stock deposited thereunder promptly after termination or withdrawal of the Exchange Offer), or to terminate the Exchange Offer and not accept for exchange any shares of Common Stock not previously accepted, (i) if any of the conditions to the Exchange Offer shall not have been satisfied or validly waived by us, or (ii) in order to comply in whole or in part with any applicable law. In all cases, the issuance of Junior Series B Participating Preferred Stock in exchange for shares of Common Stock validly tendered and not withdrawn pursuant to the Exchange Offer will be made only after timely receipt by the Exchange Agent of (1) timely confirmation of a book-entry transfer (a “book-entry confirmation”) of the shares of Common Stock into the Exchange Agent’s account at DTC, (2) the properly completed and duly executed Letter of Transmittal (or a facsimile thereof) or an Agent’s Message in lieu thereof and (3) any other documents required by the Letter of Transmittal.
For purposes of the Exchange Offer, we will be deemed to have accepted for exchange validly tendered (and not validly withdrawn) shares of Common Stock as provided herein when, and if, we give oral or written notice to the Exchange Agent of our acceptance of the shares of Common Stock for exchange pursuant to the Exchange Offer. In all cases, the exchange of shares of Common Stock pursuant to the Exchange Offer will be made by deposit of shares of the Junior Series B Participating Preferred Stock with the Exchange Agent, which will act as your agent for the purposes of receiving Junior Series B Participating Preferred Stock from us, and delivering Junior Series B Participating Preferred Stock to you. On and after the settlement date, the tendering holders whose shares of Common Stock have been exchanged by us will cease to be holders of Common Stock. Such tendering holders will receive the applicable shares of Junior Series B Participating Preferred Stock for the shares of Common Stock accepted for exchange.
If, for any reason whatsoever, acceptance for exchange of any shares of Common Stock validly tendered and not withdrawn pursuant to the Exchange Offer is delayed (whether before or after our acceptance for exchange of the shares of Common Stock) or we extend the Exchange Offer or are unable to accept for exchange the shares of Common Stock validly tendered and not withdrawn pursuant to the Exchange Offer, then, without prejudice to our rights set forth herein, we may instruct the Exchange Agent to retain validly tendered shares of Common Stock and those shares may not be withdrawn, subject to the circumstances described in “— Withdrawal Rights” below.
On the settlement date, we will issue shares of Junior Series B Participating Preferred Stock in exchange for shares of Common Stock for the tendering holders. Shares of Common Stock that we acquire pursuant to this Exchange Offer will be cancelled and will be available for us to issue without further stockholder action (except as required by applicable law or the rules of the NYSE) for purposes including, without limitation, acquisitions, raising additional capital and the satisfaction of obligations under existing or future employee benefit or compensation programs or stock plans or compensation programs for directors.
We reserve the right to transfer or assign, in whole or from time to time in part, to one or more of our respective affiliates, the right to acquire all or any portion of the shares of Common Stock tendered pursuant to the Exchange Offer and any such transfer or assignment will in no way prejudice the right of tendering holders to receive the appropriate number of shares of Junior Series B Participating Preferred Stock in exchange for the shares of Common Stock validly tendered and not validly withdrawn prior to the Expiration Date that have been accepted for exchange pursuant to the Exchange Offer.
We will not be liable for any interest as a result of a delay by the Exchange Agent or DTC in distributing shares of the Junior Series B Participating Preferred Stock issued in the Exchange Offer.
The Company’s transfer agent is Computershare Trust Company, N.A.
Expiration; Extensions; Termination; Amendment
For purposes of the Exchange Offer, the Expiration Date is one minute following 11:59 P.M. (12:00 midnight), New York City Time, on December 15, 2026, subject to our right to extend that time and date with respect to the Exchange Offer in our absolute discretion, in which case the Expiration Date means the latest time and date to which the Exchange Offer is extended.
In addition, we may terminate the Exchange Offer if any condition listed under “— Conditions to the Exchange Offer” is not satisfied at or prior to the Expiration Date. In any such event, the shares of Common Stock previously tendered pursuant to the Exchange Offer will be promptly returned to the tendering
 
30

Table of Contents
 
holders. Any extension, amendment, waiver or decrease or change will not result in the reinstatement of any withdrawal rights if those rights had previously expired, except as specifically provided above.
Subject to the applicable regulations of the SEC, we expressly reserve the right, in our sole discretion, at any time and from time to time, and regardless of whether any events preventing satisfaction of the conditions to the Exchange Offer shall have occurred or shall have been determined by us to have occurred, to extend the period during which the Exchange Offer is open by giving oral (to be confirmed in writing) or written notice of such extension to the Exchange Agent and by making public disclosure by press release or other appropriate means of such extension to the extent required by law. During any extension of the Exchange Offer, all shares of Common Stock previously tendered and not withdrawn will remain subject to the Exchange Offer and may, subject to the terms and conditions of the Exchange Offer, be accepted for exchange by us. See also “— Announcements.”
Any waiver, amendment or modification of the Exchange Offer will apply to all shares of Common Stock tendered pursuant to the Exchange Offer. If we make a change that we determine to be material in any of the terms of the Exchange Offer or waive a condition of the Exchange Offer that we determine to be material, we will give oral (to be confirmed in writing) or written notice of such amendment or such waiver to the Exchange Agent and will disseminate additional Exchange Offer documents and extend the Exchange Offer and withdrawal rights as we determine necessary and to the extent required by law.
There can be no assurance that we will exercise our right to extend, terminate or amend the Exchange Offer. During any extension and irrespective of any amendment to the Exchange Offer, all shares of Common Stock previously tendered and not withdrawn will remain subject to the Exchange Offer and may be accepted thereafter for exchange by us, subject to compliance with applicable law. In addition, we may waive conditions without extending the Exchange Offer in accordance with applicable law.
Announcements
Any extension, termination or amendment of the Exchange Offer will be followed as promptly as practicable by announcement thereof, such announcement in the case of an extension of the Exchange Offer to be issued no later than 9:00 a.m., New York City Time, on the next business day following the previously scheduled expiration date. Without limiting the manner in which we may choose to make such announcement, we will not, unless otherwise required by law, have any obligation to publish, advertise or otherwise communicate any such announcement other than by making a release to an appropriate news agency or another means of announcement that we deem appropriate.
Withdrawal Rights
You may validly withdraw shares of Common Stock that you tender at any time prior to the Expiration Date of the Exchange Offer, which is one minute following 11:59 P.M. (12:00 midnight), New York City Time, on December 15, 2026, unless extended by us. In addition, if not previously returned, you may withdraw any shares of Common Stock that you tender that are not accepted by us for exchange after the expiration of 40 business days from the commencement of the Exchange Offer. You may also validly withdraw shares of Common Stock that you tender if the Exchange Offer is terminated without any shares of Common Stock being accepted or as required by applicable law. If such a termination occurs, the shares of Common Stock will be returned to the tendering holder as promptly as practicable.
A holder who validly withdraws previously tendered shares of Common Stock prior to the Expiration Date and does not validly re-tender shares of Common Stock prior to the Expiration Date will not receive shares of Junior Series B Participating Preferred Stock. A holder of shares of Common Stock who validly withdraws previously tendered shares of Common Stock prior to the Expiration Date and validly re-tenders shares of Common Stock prior to the Expiration Date will receive shares of Junior Series B Participating Preferred Stock.
If you wish to withdraw shares of Common Stock that you previously tendered through a bank, broker, custodian or other nominee, you should contact your bank, broker, custodian or other nominee for instructions on how to withdraw your shares of Common Stock.
 
31

Table of Contents
 
To be effective, a written or facsimile transmission notice of withdrawal of a tender or a properly transmitted request via DTC must:
•
be received by the Exchange Agent at one of the addresses specified on the back cover of this Offer to Exchange prior to the Expiration Date (or, if we have not previously accepted your shares of Common Stock for exchange, after the expiration of 40 business days after the commencement of the Exchange Offer),
​
•
specify the name of the person who tendered the shares of Common Stock to be withdrawn and the name of the DTC participant whose name appears on the security position listing as the owner of such shares of Common Stock, if different from that of the person who deposited the shares of Common Stock,
​
•
specify the number of shares of Common Stock to be withdrawn,
​
•
unless transmitted through ATOP, be signed by the holder thereof in the same manner as the original signature on the Letter of Transmittal, including any required signature guarantee(s),
​
•
contain a statement that such holder of shares of Common Stock is withdrawing the election to tender its shares of Common Stock, and
​
•
if the Letter of Transmittal was executed by a person other than the DTC participant whose name appears on a security position listing as the owner of the shares of Common Stock, be accompanied by a properly completed irrevocable proxy that authorizes such person to effect such withdrawal on behalf of such holder.
​
If the shares of Common Stock to be withdrawn have been delivered or otherwise identified to the Exchange Agent, a signed notice of withdrawal is effective immediately upon receipt by the Exchange Agent of written or facsimile transmission of the notice of withdrawal (or receipt of a request via DTC) even if physical release is not yet effected. A withdrawal of tendered shares of Common Stock can only be accomplished in accordance with the foregoing procedures.
We will have the right, which we may waive, to reject a defective tender of shares of Common Stock as invalid and ineffective. If we waive our rights to reject a defective tender of shares of Common Stock, subject to the other terms and conditions set forth in this Offer to Exchange and the accompanying Letter of Transmittal, you will be entitled to receive the number of shares of Junior Series B Participating Preferred Stock offered pursuant to the Exchange Offer in respect of the defectively tendered shares of Common Stock.
If you withdraw shares of Common Stock, you will have the right to re-tender them prior to the Expiration Date in accordance with the procedures described above for tendering outstanding shares of Common Stock. If we amend or modify the terms of the Exchange Offer or the information concerning the Exchange Offer in a manner determined by us to constitute a material change to the Exchange Offer, we will disseminate additional offer materials and if, at the time notice of any such amendment or modification is first published, sent or given to holders of Common Stock, the Exchange Offer is scheduled to expire at any time earlier than the tenth business day from and including the date that such notice is first so published, sent or given, the Exchange Offer will be extended until no sooner than the expiration of such ten business day period. An extension of the Expiration Date will not affect a holder’s withdrawal rights, unless otherwise provided or as required by applicable law.
Exchange Agent
Computershare Trust Company, N.A. is serving as the Exchange Agent in connection with the Exchange Offer.
Information Agent
MacKenzie Partners, Inc. is serving as Information Agent in connection with the Exchange Offer. The Information Agent will assist with the mailing of this Offer to Exchange and related materials to holders of shares of Common Stock, respond to inquiries of and provide information to holders of shares of Common Stock in connection with the Exchange Offer, and provide other similar advisory services as we may request from time to time. Questions regarding the terms of the Exchange Offer, and requests for
 
32

Table of Contents
 
assistance or for additional copies of this Offer to Exchange and any other required documents, may be directed to the Information Agent at the email address and telephone number set forth on the back cover of this Offer to Exchange.
Fees and Expenses
We have agreed to pay customary compensation to the Information Agent and the Exchange Agent for their respective services and to reimburse them for reasonable out-of-pocket expenses. We have agreed to indemnify the Information Agent and the Exchange Agent against certain liabilities in connection with the Exchange Offer, including certain liabilities under the federal securities laws.
No brokerage commissions will be payable by tendering holders of Common Stock to us, the Information Agent or the Exchange Agent. If you hold your shares through a bank, broker or nominee, such firm may charge you a fee for exchanging your shares of Common Stock. You should consult your bank or broker nominee to determine whether any charges will apply.
Interests of our directors, executive officers and affiliates in the Exchange Offer
To our knowledge, none of our affiliates, directors or executive officers is a party to any contract, arrangement, understanding or agreement with any other person relating, directly or indirectly, to the Exchange Offer. None of the directors or executive officers that own shares of Common Stock has advised us that they currently intend to tender such shares in the Exchange Offer. However, it is possible that one or more of our directors or executive officers who own shares of Common Stock may elect to tender some or all of their shares of Common Stock in the Exchange Offer.
 
33

Table of Contents​
 
DESCRIPTION OF JUNIOR SERIES B PARTICIPATING CUMULATIVE REDEEMABLE PREFERRED STOCK
This summary includes a description of the material terms and provisions of the Junior Series B Participating Preferred Stock. The following summary does not purport to be complete and is qualified in its entirety by reference to our charter, including the Articles Supplementary setting forth the terms of the Junior Series B Participating Preferred Stock, and our bylaws, as amended, each of which is available from us and is or will be filed with the SEC. We encourage you to read the form of Articles Supplementary of the Junior Series B Participating Cumulative Redeemable Preferred Stock, which will be filed with an amendment to the Schedule TO-I of which this Offer to Exchange forms a part, carefully and in its entirety.
General
We are authorized to issue up to 395,000,000 shares of capital stock, $0.01 par value per share, in one or more classes or series and, subject to the limitations prescribed by our charter and Maryland law, with such terms of each class or series of preferred stock, including preferences, conversion or other rights, voting power, restrictions, limitations as to dividends or other distributions, qualifications, and terms and conditions of redemption and the number of shares constituting any class or series, as our Board of Directors may determine, without any vote or action by our stockholders. Our charter authorizes our Board of Directors to classify from time to time any unissued shares of stock in one or more classes or series of preferred stock and to reclassify any previously classified but unissued preferred stock of any class or series in one or more classes or series.
In connection with this Exchange Offer, our Board of Directors and a duly authorized pricing committee of our Board of Directors have authorized the reclassification of our authorized and unissued shares of capital stock into a series of 12.00% Junior Series B Participating Cumulative Redeemable Preferred Stock. When issued in accordance with this Offer to Exchange, the Junior Series B Participating Preferred Stock will be validly issued, fully paid and nonassessable. Our Board of Directors may authorize the issuance and sale of additional shares of Junior Series B Participating Preferred Stock from time to time.
We intend to file an application to list the Junior Series B Participating Preferred Stock on the NYSE under the symbol “RWT PRB”. We will use commercially reasonable efforts to have the listing application for the Junior Series B Participating Preferred Stock approved. If the application is approved, trading of the Junior Series B Participating Preferred Stock on the NYSE is expected to commence within thirty days after the date of initial delivery of the Junior Series B Participating Preferred Stock.
Maturity
The Junior Series B Participating Preferred Stock has no stated maturity and will not be subject to any sinking fund or mandatory redemption. Shares of the Junior Series B Participating Preferred Stock will remain outstanding indefinitely unless we decide to redeem or otherwise repurchase them or they are automatically converted into shares of our Common Stock in a Change of Control as described below under “— Automatic Conversion.” We are not required to set aside funds to redeem the Junior Series B Participating Preferred Stock.
Ranking
The Junior Series B Participating Preferred Stock will rank, with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up:
(1)   senior to all classes or series of our Common Stock, to our Series X Preferred Stock and to all other equity securities issued by us other than equity securities referred to in clauses (2) and (3);
(2)   on a parity with all equity securities issued by us with terms specifically providing that those equity securities rank on a parity with the Junior Series B Participating Preferred Stock with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up;
 
34

Table of Contents
 
(3)   junior to our Series A Preferred Stock and to all other equity securities issued by us with terms specifically providing that those equity securities rank senior to the Junior Series B Participating Preferred Stock with respect to rights to the payment of dividends and the distribution of assets upon our liquidation, dissolution or winding up; and
(4)   effectively junior to all of our existing and future indebtedness (including indebtedness convertible to our Common Stock or preferred stock) and to the indebtedness of our existing subsidiaries and any future subsidiaries.
Dividends
Holders of shares of the Junior Series B Participating Preferred Stock are entitled to receive, when, as and if authorized by our Board of Directors and declared by us, out of funds legally available for the payment of dividends, cumulative cash dividends at a fixed rate of 12.00% per annum based on the liquidation preference stated at $25.00 per share. The dividend rate is fixed and is not subject to reset. A “Dividend Period” means the period from, and including, each Dividend Payment Date to, but excluding, the next succeeding Dividend Payment Date, except for the initial Dividend Period, which will be the period from, and including, the issue date of the Junior Series B Participating Preferred Stock to, but excluding, the next succeeding Dividend Payment Date. Dividends on the Junior Series B Participating Preferred Stock shall accumulate daily and be cumulative from, and including, the date of original issue and shall be payable quarterly in arrears on the 15th day of each April, July, October and January; provided that if any Dividend Payment Date is not a business day, as defined in the Articles Supplementary, then the dividend which would otherwise have been payable on that Dividend Payment Date may be paid on the next succeeding business day and no interest, additional dividends or other sums will accrue on the amount so payable for the period from and after that Dividend Payment Date to that next succeeding business day. Dividends will be calculated on the basis of a 360-day year consisting of twelve 30-day months. Dividends will be payable to holders of record as they appear in our stock records for the Junior Series B Participating Preferred Stock at the close of business on the applicable record date, which shall be the first day of the calendar month, whether or not a business day, in which the applicable Dividend Payment Date falls (each, a “Dividend Record Date”). The dividends payable on any Dividend Payment Date shall include dividends accumulated up to, but not including, such Dividend Payment Date.
No dividends on shares of Junior Series B Participating Preferred Stock shall be authorized by our Board of Directors or paid or set apart for payment by us at any time unless full cumulative dividends on the Series A Preferred Stock have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof is set apart for payment for all past dividend periods of Series A Preferred Stock or when the terms and provisions of any agreement of ours, including any agreement relating to our indebtedness, prohibit the authorization, payment or setting apart for payment thereof or provide that the authorization, payment or setting apart for payment thereof would constitute a breach of the agreement or a default under the agreement, or if the authorization, payment or setting apart for payment shall be restricted or prohibited by law. You should review the information appearing above under “Risk Factors — Risks Related to the Junior Series B Participating Preferred Stock.”
Notwithstanding the foregoing, dividends on the Junior Series B Participating Preferred Stock will accumulate whether or not we have earnings, whether or not there are assets legally available for the payment of those dividends and whether or not those dividends are authorized or declared. No interest, or sum in lieu of interest, will be payable in respect of any dividend payment or payments on the Junior Series B Participating Preferred Stock which may be in arrears, and holders of the Junior Series B Participating Preferred Stock will not be entitled to any dividends in excess of full cumulative dividends described above. Any dividend payment made on the Junior Series B Participating Preferred Stock shall first be credited against the earliest accumulated but unpaid dividend due with respect to those shares.
Future distributions on our Common Stock and preferred stock, including the Junior Series B Participating Preferred Stock, will be at the discretion of our Board of Directors and will depend on, among other things, our results of operations, cash flow from operations, financial condition and capital requirements, the annual distribution requirements under the REIT provisions of the Code for so long as we remain a REIT, any debt service requirements, any unpaid dividends on Series A Preferred Stock and any other factors our Board of Directors deems relevant. Accordingly, we cannot guarantee that we will be able
 
35

Table of Contents
 
to make cash distributions on our Junior Series B Participating Preferred Stock or what the actual distributions will be for any future period.
Unless full cumulative dividends on the Junior Series B Participating Preferred Stock have been or contemporaneously are declared and paid, or declared and a sum sufficient for the payment thereof is set apart for payment for all past Dividend Periods, no dividends (other than in shares of Common Stock or in shares of any series of preferred stock that we may issue ranking junior to the Junior Series B Participating Preferred Stock as to dividends and upon liquidation) shall be declared or paid or set aside for payment upon shares of our Common Stock or preferred stock that we may issue ranking junior to or on a parity with the Junior Series B Participating Preferred Stock as to dividends or upon liquidation. Nor shall any other distribution be declared or made upon shares of our Common Stock or preferred stock that we may issue ranking junior to or on a parity with the Junior Series B Participating Preferred Stock as to dividends or upon liquidation. In addition, any shares of our Common Stock or preferred stock that we may issue ranking junior to or on a parity with the Junior Series B Participating Preferred Stock as to dividends or upon liquidation shall not be redeemed, purchased or otherwise acquired for any consideration (or any moneys be paid to or made available for a sinking fund for the redemption of any such shares) by us (except (a) by conversion into or exchange for our other capital stock that we may issue ranking junior to the Junior Series B Participating Preferred Stock as to dividends and upon liquidation, (b) for transfers made pursuant to the provisions of our charter, relating to restrictions on ownership and transfers of our capital stock and (c) pursuant to a purchase or exchange offer made on the same terms to holders of all outstanding shares of Junior Series B Participating Preferred Stock and any preferred stock that we may issue ranking on a parity with the Junior Series B Participating Preferred Stock as to the payment of dividends or the distribution of assets upon liquidation, dissolution or winding up). The foregoing will not, however, prevent the redemption, purchase or acquisition by us of shares of any class or series of stock for the purpose of enforcing restrictions on transfer and ownership of our stock contained in our charter or in connection with the Tax Benefits Preservation Plan, or the redemption, purchase or acquisition by us of shares of our Common Stock for purposes of and in compliance with any incentive or benefit plan of ours.
When dividends are not paid in full (or a sum sufficient for such full payment is not so set apart) upon the Junior Series B Participating Preferred Stock and the shares of any other series of preferred stock that we have issued or may issue ranking on a parity as to dividends with the Junior Series B Participating Preferred Stock, all dividends declared upon the Junior Series B Participating Preferred Stock and any other series of preferred stock that we have issued or may issue ranking on a parity as to dividends with the Junior Series B Participating Preferred Stock shall be declared pro rata so that the amount of dividends declared per share of Junior Series B Participating Preferred Stock and such other series of preferred stock that we have issued or may issue shall in all cases bear to each other the same ratio that accumulated dividends per share on the Junior Series B Participating Preferred Stock and accumulated or accrued dividends per share on such other series of preferred stock that we have issued or may issue (which shall not include any accrual in respect of unpaid dividends for prior Dividend Periods if such preferred stock does not have a cumulative dividend) bear to each other. No interest, or sum of money in lieu of interest, shall be payable in respect of any dividend payment or payments on the Junior Series B Participating Preferred Stock which may be in arrears.
Liquidation Price
In the event of our voluntary or involuntary liquidation, dissolution or winding up, the holders of shares of Junior Series B Participating Preferred Stock will be entitled to be paid out of the assets we have legally available for distribution to our stockholders, subject to the preferential rights of the holders of our Series A Preferred Stock and of any other class or series of our capital stock we may issue ranking senior to the Junior Series B Participating Preferred Stock with respect to the distribution of assets upon liquidation, dissolution or winding up, a liquidation price equal to the Optional Redemption Price (with the references to redemption in such definition replaced with the relevant voluntary or involuntary liquidation, dissolution or winding up), before any distribution of assets is made to holders of our Common Stock or any other class or series of our stock that we may issue that ranks junior to the Junior Series B Participating Preferred Stock as to liquidation rights.
In the event that, upon any such voluntary or involuntary liquidation, dissolution or winding up, our available assets are insufficient to pay the amount of the liquidating distributions on all outstanding shares
 
36

Table of Contents
 
of Junior Series B Participating Preferred Stock and the corresponding amounts payable on all shares of other classes or series of our capital stock that we have issued or may issue ranking on a parity with the Junior Series B Participating Preferred Stock in the distribution of assets, then the holders of the Junior Series B Participating Preferred Stock and all other such classes or series of capital stock shall share ratably in any such distribution of assets in proportion to the full liquidating distributions to which they would otherwise be respectively entitled.
Holders of Junior Series B Participating Preferred Stock will be entitled to written notice of any such liquidation no fewer than 30 days and no more than 60 days prior to the payment date. After payment of the full amount of the liquidating distributions to which they are entitled, the holders of Junior Series B Participating Preferred Stock will have no right or claim to any of our remaining assets. The consolidation or merger of us with or into any other corporation, trust or entity or of any other entity with or into us, or the sale, lease, transfer or conveyance of all or substantially all of our property or business, shall not be deemed to constitute a liquidation, dissolution or winding up of us (although such events may give rise to the special optional redemption and automatic conversion described below).
Redemption
The Junior Series B Participating Preferred Stock will not be redeemable by us prior to the first anniversary of the Original Issuance Date of the Junior Series B Participating Preferred Stock, except as described below under “— Special Optional Redemption” and except that we may purchase or redeem shares of the Junior Series B Participating Preferred Stock prior to that date at the Optional Redemption Price in order to preserve our qualification as a REIT for federal income tax purposes or pursuant to the terms in the Articles Supplementary limiting beneficial ownership of the Junior Series B Participating Preferred Stock.
Optional Redemption; Optional Redemption Price
On and after the first anniversary of the Original Issuance Date of the Junior Series B Participating Preferred Stock, we may, at our option, upon not less than 30 nor more than 60 days’ written notice, redeem the Junior Series B Participating Preferred Stock, in whole or in part, at any time or from time to time, for cash at a redemption price per share equal to the greater of:
(i)
an amount equal to:
​
(x) the arithmetic average of the VWAP of the Common Stock for the 5 consecutive trading days commencing on the 11th trading day following the commencement of this Exchange Offer (the “Original Issuance Common Stock Price”) multiplied by the Exchange Ratio (the “Initial Exchanged Value”);
multiplied by
(y) a factor of 1 + (70% multiplied by [(the arithmetic average of the VWAP of the Common Stock for the 5 consecutive trading days commencing on the 11th trading day following the announcement of the relevant redemption (subject to customary adjustments for future stock splits) divided by the Original Issuance Common Stock Price) minus one]); and
(ii)
the Initial Exchanged Value;
​
in each case, less cumulative dividends already paid and accrued and unpaid dividends thereon to, but not including, the date fixed for redemption on such share, subject to a floor of $0, plus accrued and unpaid dividends thereon to, but not including, the date fixed for redemption (such redemption price, the “Optional Redemption Price”).
If we elect to redeem any shares of Junior Series B Participating Preferred Stock as described in this paragraph, we may use any available cash to pay the redemption price, and we will not be required to pay the redemption price only out of the proceeds from the issuance of other equity securities or any other specific source.
“VWAP” means, for any trading day, the per share volume-weighted average price of our Common Stock as displayed under the heading “Bloomberg VWAP” on Bloomberg page “RWT <Equity> AQR” ​(or
 
37

Table of Contents
 
its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such trading day (or, if such volume-weighted average price is unavailable, the market value of one share of our Common Stock on such trading day determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained by us for this purpose).
Special Optional Redemption
Upon the occurrence of a Change of Control, we may, at our option, upon not less than 30 nor more than 60 days’ written notice, redeem the Junior Series B Participating Preferred Stock, in whole or in part, on or within 120 days after the first date on which such Change of Control occurred, for cash at the Optional Redemption Price notwithstanding that such redemption occurs prior to the first anniversary of the Original Issuance Date. If, prior to the Change of Control Conversion Date, we have provided notice of our election to redeem some or all of the shares of Junior Series B Participating Preferred Stock (whether pursuant to our optional redemption right described above under “— Optional Redemption” or this special optional redemption right), the shares called for redemption will be redeemed and will not be subject to the Change of Control Conversion described below under “— Automatic Conversion.” If we elect to redeem any shares of the Junior Series B Participating Preferred Stock as described in this paragraph, we may use any available cash to pay the redemption price, and we will not be required to pay the redemption price only out of the proceeds from the issuance of other equity securities or any other specific source.
A “Change of Control” is deemed to occur when, after the original issuance of the Junior Series B Participating Preferred Stock, the following have occurred and are continuing:
•
the acquisition by any person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Exchange Act, of beneficial ownership, directly or indirectly, through a purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition transactions of our capital stock entitling that person to exercise more than 50% of the total voting power of all our capital stock entitled to vote generally in the election of our directors (except that such person will be deemed to have beneficial ownership of all securities that such person has the right to acquire, whether such right is currently exercisable or is exercisable only upon the occurrence of a subsequent condition); and
​
•
following the closing of any transaction referred to in the bullet point above, neither we nor the acquiring or surviving entity has a class of common securities (or American Depositary Receipts representing such securities) listed on the New York Stock Exchange, the NYSE American or the Nasdaq Global Select Market, or listed or quoted on an exchange or quotation system that is a successor to the New York Stock Exchange, the NYSE American or the Nasdaq Global Select Market.
​
Redemption Procedures
In the event we elect to redeem any shares of Junior Series B Participating Preferred Stock, the notice of redemption will be mailed to each holder of record of Junior Series B Participating Preferred Stock called for redemption at such holder’s address as it appears on our stock transfer records and will state the following:
•
the redemption date;
​
•
the number of shares of Junior Series B Participating Preferred Stock to be redeemed;
​
•
the redemption price;
​
•
the place or places where certificates (if any) for the Junior Series B Participating Preferred Stock are to be surrendered for payment of the redemption price;
​
•
that dividends on the shares to be redeemed will cease to accumulate on the redemption date;
​
•
whether such redemption is being made pursuant to the provisions described above under “— Optional Redemption” or “— Special Optional Redemption”;
​
 
38

Table of Contents
 
•
if applicable, that such redemption is being made in connection with a Change of Control and, in that case, a brief description of the transaction or transactions constituting such Change of Control; and
​
•
if such redemption is being made in connection with a Change of Control, that the shares of Junior Series B Participating Preferred Stock being so called for redemption will not be converted in connection with the Change of Control.
​
If less than all of the shares of Junior Series B Participating Preferred Stock held by any holder are to be redeemed, the notice mailed to such holder shall also specify the number of shares of Junior Series B Participating Preferred Stock held by such holder to be redeemed. No failure to give such notice or any defect thereto or in the mailing thereof shall affect the validity of the proceedings for the redemption of any shares of Junior Series B Participating Preferred Stock except as to the holder for whom both of the following are true: (i) notice to such holder was defective or not given and (ii) such holder does not receive the redemption price on the redemption date.
Holders of Junior Series B Participating Preferred Stock to be redeemed shall surrender the Junior Series B Participating Preferred Stock at the place designated in the notice of redemption and shall be entitled to the redemption price and any accumulated and unpaid dividends payable upon the redemption following the surrender. If notice of redemption of any shares of Junior Series B Participating Preferred Stock has been given and if we have irrevocably set aside the funds necessary for redemption in trust for the benefit of the holders of the shares of Junior Series B Participating Preferred Stock so called for redemption, then from and after the redemption date (unless default shall be made by us in providing for the payment of the redemption price plus accumulated and unpaid dividends, if any), dividends will cease to accumulate on those shares of Junior Series B Participating Preferred Stock, those shares of Junior Series B Participating Preferred Stock shall no longer be deemed outstanding and all rights of the holders of those shares will terminate, except the right to receive the redemption price plus accumulated and unpaid dividends, if any, payable upon redemption. If any redemption date is not a business day, then the redemption price and accumulated and unpaid dividends, if any, payable upon redemption may be paid on the next business day and no interest, additional dividends or other sums will accrue on the amount payable for the period from and after that redemption date to that next business day. If less than all of the outstanding Junior Series B Participating Preferred Stock is to be redeemed, the Junior Series B Participating Preferred Stock to be redeemed shall be selected pro rata (as nearly as may be practicable without creating fractional shares) or by any other equitable method we determine but that will not result in the automatic transfer of any shares of Junior Series B Participating Preferred Stock to a trust as described below under “— Restrictions on Ownership and Transfer.”
Immediately prior to any redemption of Junior Series B Participating Preferred Stock, we shall pay, in cash, any accumulated and unpaid dividends through and including the redemption date, unless a redemption date falls after a Dividend Record Date and prior to the corresponding Dividend Payment Date, in which case each holder of Junior Series B Participating Preferred Stock at the close of business on such Dividend Record Date shall be entitled to the dividend payable on such shares on the corresponding Dividend Payment Date notwithstanding the redemption of such shares before such Dividend Payment Date. Except as provided above, we will make no payment or allowance for unpaid dividends, whether or not in arrears, on shares of the Junior Series B Participating Preferred Stock to be redeemed.
Unless full cumulative dividends on all shares of Junior Series B Participating Preferred Stock shall have been or contemporaneously are declared and paid or declared and a sum sufficient for the payment thereof has been or contemporaneously is set apart for payment for all past Dividend Periods, no shares of Junior Series B Participating Preferred Stock shall be redeemed unless all outstanding shares of Junior Series B Participating Preferred Stock are simultaneously redeemed and we shall not purchase or otherwise acquire directly or indirectly any shares of Junior Series B Participating Preferred Stock (except by exchanging it for our capital stock ranking junior to the Junior Series B Participating Preferred Stock as to dividends and upon liquidation); provided, however, that the foregoing shall not prevent the purchase or acquisition by us of shares of Junior Series B Participating Preferred Stock to preserve our REIT status for federal income tax purposes or pursuant to a purchase or exchange offer made on the same terms to holders of all outstanding shares of Junior Series B Participating Preferred Stock or pursuant to the terms in the Articles Supplementary limiting beneficial ownership of the Junior Series B Participating Preferred Stock.
 
39

Table of Contents
 
Subject to applicable law, we may purchase shares of Junior Series B Participating Preferred Stock in the open market, by tender or by private agreement. Any shares of Junior Series B Participating Preferred Stock that we acquire will return to the status of authorized but unissued shares of Junior Series B Participating Preferred Stock until reclassified pursuant to our charter.
Automatic Conversion
Upon the occurrence of a Change of Control, if we do not elect to exercise our special optional redemption right described above under “— Redemption-Special Optional Redemption” with respect to all of the shares of Junior Series B Participating Preferred Stock (in which case only shares not called for redemption will be converted), each outstanding share of Junior Series B Participating Preferred Stock will automatically convert (the “Change of Control Conversion”) on the Change of Control Conversion Date into a number of shares of our Common Stock (such shares, the “Common Stock Conversion Consideration”) equal to the lesser of:
•
the quotient obtained by dividing (i) the Optional Redemption Price (with the references to redemption in such definition replaced with Change of Control) by (ii) the Common Stock Price (defined below); and
​
•
15.16 per share of Junior Series B Participating Preferred Stock (the “Share Cap”), subject to customary adjustments for future stock splits.
​
Anything in the Articles Supplementary to the contrary notwithstanding and except as otherwise required by law, the persons who are the holders of record of shares of Junior Series B Participating Preferred Stock at the close of business on a Dividend Record Date will be entitled to receive the dividend payable on the corresponding Dividend Payment Date notwithstanding the conversion of those shares after such Dividend Record Date and on or prior to such Dividend Payment Date and, in such case, the full amount of such dividend shall be paid on such Dividend Payment Date to the persons who were the holders of record at the close of business on such Dividend Record Date. Except as provided above, we will make no allowance for unpaid dividends that are not in arrears on the shares of Junior Series B Participating Preferred Stock to be converted.
In the case of a Change of Control pursuant to which our Common Stock is or will be converted into cash, securities or other property or assets (including any combination thereof) (the “Alternative Form Consideration”), a holder of Junior Series B Participating Preferred Stock will receive upon conversion of such Junior Series B Participating Preferred Stock the kind and amount of Alternative Form Consideration which such holder would have owned or been entitled to receive upon the Change of Control had such holder held a number of shares of our Common Stock equal to the Common Stock Conversion Consideration immediately prior to the effective time of the Change of Control (the “Alternative Conversion Consideration”; the Common Stock Conversion Consideration or the Alternative Conversion Consideration, whichever shall be applicable to a Change of Control, is referred to as the “Conversion Consideration”).
If the holders of our Common Stock have the opportunity to elect the form of consideration to be received in the Change of Control, the Conversion Consideration in respect of such Change of Control will be deemed to be the kind and amount of consideration actually received by holders of a majority of the outstanding shares of our Common Stock that made or voted for such an election (if electing among two types of consideration) or holders of a plurality of the outstanding shares of our Common Stock that made or voted for such an election (if electing among more than two types of consideration), as the case may be, and will be subject to any limitations to which all holders of our Common Stock are subject, including, without limitation, pro rata reductions applicable to any portion of the consideration payable in such Change of Control.
We will not issue fractional shares of our Common Stock upon the conversion of the Junior Series B Participating Preferred Stock in connection with a Change of Control. Instead, we will make a cash payment equal to the value of such fractional shares based upon the Common Stock Price used in determining the Common Stock Conversion Consideration for such Change of Control.
Within 15 days following the occurrence of a Change of Control, provided that we have not then exercised our right to redeem all shares of Junior Series B Participating Preferred Stock pursuant to the
 
40

Table of Contents
 
redemption provisions described above, we will provide to holders of Junior Series B Participating Preferred Stock a notice of occurrence of the Change of Control that describes the resulting Change of Control Conversion. This notice will be delivered to the holders of record of the shares of Junior Series B Participating Preferred Stock at their addresses as they appear on our stock transfer records. No failure to give such notice or any defect thereto or in the giving thereof will affect the validity of the proceedings for the conversion of any shares of Junior Series B Participating Preferred Stock except as to the holder to whom notice was defective or not given. This notice will state the following:
•
the events constituting the Change of Control;
​
•
the date of the Change of Control;
​
•
the method and period for calculating the Common Stock Price;
​
•
the Change of Control Conversion Date;
​
•
that if, prior to the Change of Control Conversion Date, we have provided notice of our election to redeem all or any shares of Junior Series B Participating Preferred Stock, the shares of Junior Series B Participating Preferred Stock called for redemption will be redeemed on the related redemption date instead of being converted on the Change of Control Conversion Date;
​
•
if applicable, the type and amount of Alternative Conversion Consideration entitled to be received per share of Junior Series B Participating Preferred Stock; and
​
•
the name and address of the paying agent, transfer agent and conversion agent for the Junior Series B Participating Preferred Stock.
​
Under such circumstances, we will also issue a press release containing such notice for publication on Dow Jones & Company, Inc., the Wall Street Journal, Business Wire, PR Newswire or Bloomberg Business News (or, if these organizations are not in existence at the time of issuance of the press release, such other news or press organization as is reasonably calculated to broadly disseminate the relevant information to the public), and post a notice on our website, in any event prior to the opening of business on the first business day following any date on which we provide the notice described above to the holders of Junior Series B Participating Preferred Stock.
The Change of Control Conversion will occur automatically without any action by holders, other than surrender of any certificates (or, for book-entry shares held through a Share Depositary, as defined below, in accordance with its applicable procedures) to the transfer agent.
The “Change of Control Conversion Date” is the date the Junior Series B Participating Preferred Stock is to be converted, which will be a business day selected by us that is no fewer than 20 days nor more than 35 days after the date on which we provide the notice described above to the holders of Junior Series B Participating Preferred Stock.
The “Common Stock Price” is the arithmetic average of the VWAP per share of our Common Stock for the five consecutive trading days immediately preceding, but not including, the date on which such Change of Control occurred, as reported on the principal U.S. securities exchange on which our Common Stock is then traded (or, if not so listed, as reported by OTC Markets Group Inc. or similar organization).
If any shares of Junior Series B Participating Preferred Stock are held in book-entry form through DTC or a similar depositary (each, a “Share Depositary”), the surrender of such shares for conversion must comply with applicable procedures, if any, of the applicable Share Depositary.
Shares of Junior Series B Participating Preferred Stock will be automatically converted into the applicable Conversion Consideration in accordance with the Change of Control Conversion on the Change of Control Conversion Date, unless prior to the Change of Control Conversion Date we have provided notice of our election to redeem some or all of the shares of Junior Series B Participating Preferred Stock, as described above under “— Redemption — Optional Redemption” or “— Redemption — Special Optional Redemption,” in which case only the shares of Junior Series B Participating Preferred Stock that are not called for redemption will be converted as aforesaid. If we elect to redeem shares of Junior Series B Participating Preferred Stock that would otherwise be converted into the applicable Conversion Consideration
 
41

Table of Contents
 
on a Change of Control Conversion Date, such shares of Junior Series B Participating Preferred Stock will not be so converted and the holders of such shares will be entitled to receive on the applicable redemption date the redemption price described above under “— Redemption — Optional Redemption” or “— Redemption — Special Optional Redemption,” as applicable.
We will deliver all securities, cash and any other property owing upon conversion no later than the third business day following the Change of Control Conversion Date. Notwithstanding the foregoing, the persons entitled to receive any shares of our Common Stock or other securities delivered on conversion will be deemed to have become the holders of record thereof as of the Change of Control Conversion Date.
In connection with any Change of Control Conversion, we will comply with all applicable federal and state securities laws and stock exchange rules in connection with any conversion of Junior Series B Participating Preferred Stock into shares of our Common Stock or other property. Notwithstanding any other provision of the Junior Series B Participating Preferred Stock, no holder of Junior Series B Participating Preferred Stock will be entitled to receive shares of our Common Stock to the extent that receipt of such Common Stock would cause such holder (or any other person) to exceed any applicable share ownership limitations contained in our charter that are then in effect, unless we provide an exemption from this limitation to such holder.
The Change of Control conversion feature may make it more difficult for a party to take over our company or discourage a party from taking over our company. See “Risk Factors — Risks Related to the Junior Series B Participating Preferred Stock — The Change of Control conversion feature may not adequately compensate you and may make it more difficult for a party to take over our company or discourage a party from taking over our company.”
Except as provided above in connection with a Change of Control, the Junior Series B Participating Preferred Stock is not convertible into or exchangeable for any other securities or property.
Voting Rights
Voting on Matters Submitted to Holders of the Common Stock for Vote
On any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders of the Company and on which matter holders of the Common Stock shall be entitled to vote, each share of the Junior Series B Participating Preferred Stock shall, in voting on such matter, carry the number of votes equal to the Exchange Ratio, being the number of shares of Common Stock exchanged for each share of Junior Series B Participating Preferred Stock in this Exchange Offer, subject to customary adjustments for future stock splits set forth in the Articles Supplementary of the Junior Series B Participating Preferred Stock.
Voting on Matters Related to Preferred Stock
Whenever dividends on any shares of Junior Series B Participating Preferred Stock are in arrears for six or more quarterly Dividend Periods, whether or not consecutive, the number of directors constituting our Board of Directors will, subject to the maximum number of directors authorized under our bylaws then in effect, be automatically increased by two (if not already increased by two by reason of the election of directors by the holders of our Series A Preferred Stock or any other class or series of our preferred stock that we may issue and upon which like voting rights have been conferred and are exercisable and which are entitled to vote with the Junior Series B Participating Preferred Stock as a class with respect to the election of those two directors) and the holders of Junior Series B Participating Preferred Stock, voting together as a single class with the holders of our Series A Preferred Stock (and with all other classes or series of preferred stock that we have issued or may issue and upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Junior Series B Participating Preferred Stock in the election of those two directors), will be entitled to vote, with one (1) vote per share of Junior Series B Participating Preferred Stock, for the election of those two (2) additional directors at a special meeting called by us at the request of the holders of record of at least 25% of the outstanding shares of Junior Series B Participating Preferred Stock or by the holders of our Series A Preferred Stock or any other class or series of preferred stock upon which like voting rights have been conferred and are exercisable and which are entitled
 
42

Table of Contents
 
to vote as a class with the Junior Series B Participating Preferred Stock in the election of those two directors (unless the request is received less than 90 days before the date fixed for the next annual or special meeting of stockholders, in which case, such vote will be held at the earlier of the next annual or special meeting of stockholders), and at each subsequent annual meeting until all dividends accumulated on the Junior Series B Participating Preferred Stock for all past Dividend Periods and the then current Dividend Period shall have been fully paid or declared and a sum sufficient for the payment thereof set aside for payment. In that case, the right of holders of the Junior Series B Participating Preferred Stock to elect any directors will cease and, unless there are other classes or series of our preferred stock upon which like voting rights have been conferred and are exercisable, the term of office of any directors elected by holders of the Junior Series B Participating Preferred Stock will immediately terminate and the number of directors constituting the Board of Directors shall be reduced accordingly. In no event shall the holders of Junior Series B Participating Preferred Stock be entitled pursuant to these voting rights to elect a director that would cause us to fail to satisfy a requirement relating to director independence of any national securities exchange or quotation system on which any class or series of our capital stock is listed or quoted. For the avoidance of doubt, in no event shall the total number of directors elected by holders of the Junior Series B Participating Preferred Stock and the Series A Preferred Stock (voting together as a single class with all other classes or series of preferred stock that we have issued or may issue and upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Junior Series B Participating Preferred Stock in the election of such directors) pursuant to these voting rights exceed two.
If at any time when the voting rights conferred upon the Junior Series B Participating Preferred Stock (as described above) are exercisable, any vacancy in the office of a director elected pursuant to the procedures described above shall occur, then such vacancy may be filled only by the remaining such director or by the vote of the holders of record of the outstanding Junior Series B Participating Preferred Stock, voting together as a single class with the holders of our Series A Preferred Stock and any other classes or series of preferred stock upon which like voting rights have been conferred and are exercisable and which are entitled to vote as a class with the Junior Series B Participating Preferred Stock in the election of directors (as described above). Any director elected or appointed pursuant to the procedures described above may be removed only by the affirmative vote of holders of the outstanding Junior Series B Participating Preferred Stock, voting together as a single class with the holders of our Series A Preferred Stock and any other classes or series of preferred stock upon which like voting rights have been conferred and are exercisable and which classes or series of preferred stock are entitled to vote as a class with the Junior Series B Participating Preferred Stock in the election of directors pursuant to the procedures described above, such removal to be effected by the affirmative vote of a majority of the votes entitled to be cast by the holders of the outstanding Junior Series B Participating Preferred Stock, the Series A Preferred Stock and any such other classes or series of preferred stock, and may not be removed by the holders of our Common Stock.
If a special meeting is not called by us within 30 days after request from the holders of Junior Series B Participating Preferred Stock as described above, then the holders of record of at least 25% of the outstanding Junior Series B Participating Preferred Stock may designate a holder to call the meeting at our expense.
On each matter on which holders of Junior Series B Participating Preferred Stock are entitled to vote with other classes or series of our preferred stock as a single class, the Junior Series B Participating Preferred Stock and the shares of each such other class or series will have one vote for each $25.00 of stated liquidation preference (excluding accumulated dividends).
So long as any shares of Junior Series B Participating Preferred Stock remain outstanding, we will not, without the affirmative vote or consent of the holders of at least two-thirds of the shares of the outstanding Junior Series B Participating Preferred Stock and all other parity stock having like voting rights that are exercisable at the time, voting as a single class, outstanding at the time, given in person or by proxy, either in writing or at a meeting (voting together as a single class with all series of preferred stock ranking on a parity with the Junior Series B Participating Preferred Stock that we have issued or may issue upon which like voting rights have been conferred and are exercisable), amend, alter or repeal the provisions of our charter, whether by merger, consolidation or otherwise, so as to materially and adversely affect any right, preference, privilege or voting power of the Junior Series B Participating Preferred Stock; provided, however, if the proposed amendments would materially and adversely affect the rights, preferences, privileges or voting powers of the Junior Series B Participating Preferred Stock disproportionately relative to any other class or
 
43

Table of Contents
 
series of parity stock, the affirmative vote of the holders of at least two-thirds of the outstanding Junior Series B Participating Preferred Stock, voting as a separate class, is also required; provided, further, so long as the Junior Series B Participating Preferred Stock remains outstanding with the terms thereof materially unchanged, or the holders of shares of Junior Series B Participating Preferred Stock receive securities of a successor person or entity with substantially identical rights as those of the Junior Series B Participating Preferred Stock, taking into account that, upon an occurrence of a merger, consolidation or otherwise, we may not be the surviving entity, the proposed amendments shall not be deemed to materially and adversely affect such rights, preferences, privileges or voting power of holders of the Junior Series B Participating Preferred Stock and, provided further, that any increase in the amount of the authorized preferred stock, including the Junior Series B Participating Preferred Stock, or the creation or issuance of any additional shares of Junior Series B Participating Preferred Stock or other series of preferred stock that we may issue, or any increase in the amount of authorized shares of such series, in each case ranking senior to, on a parity with or junior to the Junior Series B Participating Preferred Stock that we may issue with respect to payment of dividends or the distribution of assets upon liquidation, dissolution or winding up, shall not be deemed to materially and adversely affect such rights, preferences, privileges or voting powers.
The foregoing voting provisions will not apply if, at or prior to the time when the act with respect to which such vote would otherwise be required shall be effected, all outstanding shares of Junior Series B Participating Preferred Stock shall have been redeemed or called for redemption upon proper notice and sufficient funds shall have been deposited in trust to effect such redemption.
Except as expressly stated in the Articles Supplementary or as may be required by applicable law, the Junior Series B Participating Preferred Stock will not have any relative, participating, optional or other special voting rights or powers and the consent of the holders thereof shall not be required for the taking of any corporate action.
Information Rights
During any period in which we are not subject to Section 13 or 15(d) of the Exchange Act and any shares of Junior Series B Participating Preferred Stock are outstanding, we will use our best efforts to (i) transmit by mail (or other permissible means under the Exchange Act) to all holders of Junior Series B Participating Preferred Stock, as their names and addresses appear on our record books and without cost to such holders, copies of the annual reports on Form 10-K and quarterly reports on Form 10-Q that we would have been required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act if we were subject thereto (other than any exhibits that would have been required) and (ii) promptly, upon request, supply copies of such reports to any holder or prospective holder of Junior Series B Participating Preferred Stock. We will use our best efforts to mail (or otherwise provide) the information to the holders of the Junior Series B Participating Preferred Stock within 15 days after the respective dates by which a periodic report on Form 10-K or Form 10-Q, as the case may be, in respect of such information would have been required to be filed with the SEC, if we were subject to Section 13 or 15(d) of the Exchange Act, in each case, based on the dates on which we would be required to file such periodic reports if we were a “non-accelerated filer” within the meaning of the Exchange Act.
Restrictions on Ownership and Transfer
Our charter prohibits any person from acquiring or holding beneficial ownership (as defined in the charter) of shares of any class of our capital stock in excess of 9.8%, in number of shares or value, of the outstanding shares of such class of capital stock, until the first day on which our Board of Directors determines that it is no longer in our best interest to attempt to, or continue to, qualify as a REIT. Additionally, our Articles Supplementary establishing the terms of the Junior Series B Participating Preferred Stock will prohibit any person from acquiring or holding beneficial ownership (as defined in the Articles Supplementary) or constructive ownership (as defined in the Articles Supplementary) of shares of the Junior Series B Participating Preferred Stock in excess of 4.9%, in number of shares or value, of the outstanding shares of the Junior Series B Participating Preferred Stock, except for holders who acquire more than 4.9% of the Junior Series B Participating Preferred Stock by tendering shares of Common Stock held by them pursuant to this Exchange Offer. Any such holder owning more than 4.9% of the Junior Series B Participating Preferred Stock following the Exchange Offer may not acquire additional shares of Junior
 
44

Table of Contents
 
Series B Participating Preferred Stock, regardless of whether they have sold any shares of Junior Series B Participating Preferred Stock. In other words, such holder’s ownership limitation will be reduced accordingly following any sale or other disposition of shares of Junior Series B Participating Preferred Stock by such holder. Our Board of Directors may waive such limit on ownership.
Moreover, the constructive ownership rules applied to determine ownership under the Articles Supplementary are complex and may cause shares of Junior Series B Participating Preferred Stock owned actually or constructively by a group of related individuals and/or entities to be constructively owned by one individual or entity. As a result, the acquisition of less than 4.9% of the shares of Junior Series B Participating Preferred Stock (or the acquisition of an interest in an entity that owns, actually or constructively, Junior Series B Participating Preferred Stock) by an individual or entity could nevertheless cause that individual or entity, or another individual or entity, to own constructively in excess of 4.9% of the outstanding Junior Series B Participating Preferred Stock and thus violate the ownership limitations in our charter or the Articles Supplementary.
Any acquisition by a holder of Junior Series B Participating Preferred Stock that results in such holder violating the ownership limitations in our charter or the Articles Supplementary may not be valid. In addition, no holder of Junior Series B Participating Preferred Stock will be entitled to convert the Junior Series B Participating Preferred Stock into our Common Stock to the extent that receipt of our Common Stock would cause the holder to violate the ownership limitations in our charter or the Articles Supplementary unless we provide an exemption from these ownership limitations to such holder at our sole discretion.
In addition, we have adopted the Tax Benefits Preservation Plan intended to protect our ability to use our net operating losses and certain other tax attributes. For purposes of the Tax Benefits Preservation Plan, ownership of our Common Stock and the Junior Series B Participating Preferred Stock is aggregated. Subject to certain limitations, beneficially owning over 4.9% of the Company’s Common Stock, shares of preferred stock (other than certain non-voting, non-participating preferred stock), including Junior Series B Participating Preferred Stock, warrants, rights, convertible debt or options to purchase stock of the Company, and any other interest that would be treated as “stock” of the Company for purposes of Section 382 and the regulations thereunder may result in significant dilution to such holder under the Tax Benefits Preservation Plan unless our Board of Directors grants an exemption. For more information regarding the Tax Benefits Preservation Plan, please refer to the Company’s Current Report on Form 8-K filed with the SEC on November 3, 2026, along with the Tax Benefits Preservation Plan filed as Exhibit 4.1 therewith.
Preemptive Rights
No holders of the Junior Series B Participating Preferred Stock have any preemptive rights to purchase or subscribe for our Common Stock or any other security.
 
45

Table of Contents​
 
MATERIAL DIFFERENCES AMONG THE COMMON STOCK, SERIES A PREFERRED STOCK AND JUNIOR SERIES B PARTICIPATING PREFERRED STOCK
The following briefly summarizes the material differences among the rights of holders of Common Stock, Series A Preferred Stock, and Junior Series B Participating Preferred Stock to be issued in the Exchange Offer. The discussion below is a summary and is qualified in its entirety by reference to our Amended and Restated Articles of Incorporation and Bylaws, each as amended from time to time, Articles Supplementary for the Series A Preferred Stock, Articles Supplementary for the Junior Series B Participating Preferred Stock, and other documents referred to and incorporated by reference herein. We urge you to read these documents for a more complete understanding of the differences among the Common Stock, Series A Preferred Stock and Junior Series B Participating Preferred Stock.
​ ​ ​
Common Stock
​ ​
Series A Preferred Stock
​ ​
Junior Series B Participating
Preferred Stock
​
Maturity
​ ​ None. ​ ​ None. ​ ​ None. ​
Ranking
​ ​ Junior to Series A Preferred Stock and Junior Series B Participating Preferred Stock. ​ ​ Senior to Common Stock, Junior Series B Participating Preferred Stock and Series X Preferred Stock, on parity with equity securities expressly designated as ranking equally, and junior to equity securities expressly designated as ranking senior. ​ ​ Senior to Common Stock and Series X Preferred Stock, on parity with equity securities expressly designated as ranking equally, and junior to Series A Preferred Stock and other equity securities expressly designated as ranking senior. ​
Dividend Rights
​ ​ When, as and if authorized by the Board in amounts determined by the Board, subject to payment of dividends on the Series A Preferred Stock, Junior Series B Participating Preferred Stock, and any other senior-ranking equity securities. ​ ​ When, as and if authorized by the Board and declared by the Company, quarterly at a rate of 10.00% per annum of the $25.00 per share liquidation preference prior to April 15, 2028 and, for each reset period, the five-year U.S. Treasury Rate plus 6.278% per annum. ​ ​ When, as and if authorized by the Board and declared by the Company, quarterly at a fixed rate of 12.00% per annum of the stated $25.00 per share liquidation preference; not subject to reset. ​
Liquidation Rights
​ ​ Upon liquidation, dissolution or winding up, holders of Common Stock are entitled to share ratably in any remaining assets legally available for distribution after satisfaction of all liabilities and payment of the liquidation preferences of Series A Preferred Stock, Junior Series B Participating Preferred Stock, and any other senior-ranking equity securities. ​ ​ Upon liquidation, dissolution or winding up, holders of Series A Preferred Stock are entitled to receive $25.00 per share, plus accumulated and unpaid dividends, before any distributions to common stockholders, but after satisfaction of creditor claims and senior equity preferences. If assets are insufficient, Series A Preferred Stock shares share ratably with parity securities. ​ ​ Upon liquidation, dissolution or winding up, holders of Junior Series B Participating Preferred Stock are entitled to be paid at the Optional Redemption Price (with the references to redemption in such definition replaced with the relevant voluntary or involuntary liquidation, dissolution or winding up), before any distributions to common stockholders, but after satisfaction of creditor claims and senior equity preferences, including Series A Preferred Stock. If ​
 
46

Table of Contents
 
​ ​ ​
Common Stock
​ ​
Series A Preferred Stock
​ ​
Junior Series B Participating
Preferred Stock
​
​ ​ ​ ​ ​ ​ ​ ​ ​ assets are insufficient, Junior Series B Participating Preferred Stock shares share ratably with parity securities. ​
Redemption Rights
​ ​ The Company does not have the right to redeem shares of Common Stock. Redeemable by Company to preserve REIT status, pursuant to the “excess securities” provision of the Charter. ​ ​
Not currently subject to mandatory redemption. Beginning April 15, 2028, the Company may redeem shares, in whole or in part, at $25.00 per share plus accumulated and unpaid dividends.
Earlier redemption is permitted upon a Change of Control or to preserve REIT status. Holders do not have redemption rights.
​ ​
The Company may redeem shares, in whole or in part, on and after the first anniversary of the Original Issuance Date for cash at the Optional Redemption Price.
Earlier redemption is permitted only upon a Change of Control, to preserve REIT status or pursuant to the ownership limitation in the Articles Supplementary, at the Optional Redemption Price. Holders do not have redemption rights.
​
Voting Rights
​ ​ Entitled to one vote per share on all matters submitted to holders of Common Stock. ​ ​ Generally no voting rights, except that (i) if dividends are in arrears for six or more quarterly periods, holders may elect two additional directors, voting together with similarly entitled preferred stock holders; and (ii) approval by at least two-thirds of the outstanding Series A Preferred Stock and applicable parity preferred stock, voting as a single class, is required to authorize senior equity securities or amendments materially and adversely affecting their rights. Amendments that are disproportionately adverse to the Series A Preferred Stock require a separate class vote of the Series A Preferred Stock. Holders of the Series A Preferred Stock have the exclusive right to vote on amendments that only ​ ​ Entitled to vote on all matters submitted to holders of Common Stock, and, in voting on such matter, each share of Junior Series B Participating Preferred Stock will carry a number of votes equal to the Exchange Ratio, subject to customary adjustments for future stock splits. In addition, (i) if dividends are in arrears for six or more quarterly periods, holders may elect two additional directors, voting together with similarly entitled preferred stock holders with one vote per share of Junior Series B Participating Preferred Stock; and (ii) approval by at least two-thirds of the outstanding Junior Series B Participating Preferred Stock and applicable parity preferred stock, voting as a single class with one vote per share of Junior Series B ​
 
47

Table of Contents
 
​ ​ ​
Common Stock
​ ​
Series A Preferred Stock
​ ​
Junior Series B Participating
Preferred Stock
​
​ ​ ​ ​ ​ ​ affect the Series A Preferred Stock. ​ ​ Participating Preferred Stock, is required to authorize amendments materially and adversely affecting their rights. Amendments that are disproportionately adverse to the Junior Series B Participating Preferred Stock require a separate class vote of the Junior Series B Participating Preferred Stock. Holders of the Junior Series B Participating Preferred Stock have the exclusive right to vote on amendments that only affect the Junior Series B Participating Preferred Stock. ​
Conversion Rights
​ ​ Holders of Common Stock do not have any conversion rights. ​ ​ Holders may convert their shares into Common Stock upon a qualifying Change of Control, at a conversion rate based on the $25.00 liquidation preference plus accrued unpaid dividends, divided by the applicable common stock price, subject to a Share Cap of 6.98324 shares per preferred share (subject to adjustment). This right does not apply to shares called for redemption. In the case of a Change of Control pursuant to which our Common Stock is or will be converted into cash, securities or other property or assets (including any combination thereof) (the “Alternative Form Consideration”), a holder of Series A Preferred Stock will receive upon conversion of such Series A Preferred Stock the kind and amount of Alternative Form Consideration which such holder would have ​ ​ Upon a Change of Control, if the Company does not elect to redeem the Junior Series B Participating Preferred Stock, each outstanding share of Junior Series B Participating Preferred Stock will be automatically converted into a number of shares of Common Stock equal to the Optional Redemption Price (with the references to redemption in such definition replaced with Change of Control) divided by the Common Stock Price (five-day arithmetic average of VWAP preceding the Change of Control), subject to a Share Cap of 15.16 shares per preferred share (subject to adjustment). Shares called for redemption will be redeemed instead of converted. In the case of a Change of Control pursuant to which our Common Stock is or will be converted into Alternative ​
 
48

Table of Contents
 
​ ​ ​
Common Stock
​ ​
Series A Preferred Stock
​ ​
Junior Series B Participating
Preferred Stock
​
​ ​ ​ ​ ​ ​ owned or been entitled to receive upon the Change of Control had such holder converted such shares of Series A Preferred Stock into Common Stock immediately prior to the effective time of the Change of Control. ​ ​ Form Consideration, a holder of Junior Series B Participating Preferred Stock will receive upon conversion of such Junior Series B Participating Preferred Stock the kind and amount of Alternative Form Consideration which such holder would have owned or been entitled to receive upon the Change of Control had such holder converted such shares of Junior Series B Participating Preferred Stock into Common Stock immediately prior to the effective time of the Change of Control. ​
 
49

Table of Contents​
 
MARKET PRICE INFORMATION
Our Common Stock trades on the NYSE under the symbol “RWT.” The following table sets forth, for each of the periods indicated, the high and low sales prices per share as reported by the NYSE, based on published financial sources.
Fiscal Year Ending December 31, 2026
​ ​
High
​ ​
Low
​
First Quarter
​ ​ ​ $ 6.68 ​ ​ ​ ​ $ 5.29 ​ ​
Second Quarter
​ ​ ​ ​ 6.06 ​ ​ ​ ​ ​ 4.73 ​ ​
Third Quarter
​ ​ ​ ​ 5.21 ​ ​ ​ ​ ​ 3.55 ​ ​
Fiscal Year Ending December 31, 2025
​ ​
High
​ ​
Low
​
First Quarter
​ ​ ​ $ 6.72 ​ ​ ​ ​ $ 6.01 ​ ​
Second Quarter
​ ​ ​ ​ 6.22 ​ ​ ​ ​ ​ 4.95 ​ ​
Third Quarter
​ ​ ​ ​ 6.37 ​ ​ ​ ​ ​ 5.46 ​ ​
Fourth Quarter
​ ​ ​ ​ 5.91 ​ ​ ​ ​ ​ 5.01 ​ ​
Fiscal Year Ending December 31, 2024
​ ​
High
​ ​
Low
​
First Quarter
​ ​ ​ $ 7.25 ​ ​ ​ ​ $ 5.93 ​ ​
Second Quarter
​ ​ ​ ​ 6.68 ​ ​ ​ ​ ​ 5.49 ​ ​
Third Quarter
​ ​ ​ ​ 8.08 ​ ​ ​ ​ ​ 6.37 ​ ​
Fourth Quarter
​ ​ ​ ​ 7.70 ​ ​ ​ ​ ​ 6.44 ​ ​
 
50

Table of Contents​
 
U.S. FEDERAL INCOME TAX CONSIDERATIONS
The following discussion is a summary of U.S. federal income tax considerations generally applicable to the receipt of shares of Junior Series B Participating Preferred Stock of the Company in exchange for shares of Common Stock pursuant to the Exchange Offer, and the ownership and disposition of shares of Junior Series B Participating Preferred Stock of the Company. This discussion applies only to shares of Junior Series B Participating Preferred Stock and Common Stock held as capital assets within the meaning of the Code (generally, property held for investment) and does not describe all of the tax consequences that may be relevant to holders in light of their particular circumstances or to holders subject to special rules, such as: financial institutions; broker-dealers or traders in securities; controlled foreign corporations and passive foreign investment companies; taxpayers that are subject to the mark-to-market tax accounting rules; tax-exempt organizations (including private foundations); governments or agencies or instrumentalities thereof; partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); S corporations; insurance companies; regulated investment companies; real estate investment trusts; expatriates or former long-term residents of the United States; persons deemed to sell our Junior Series B Participating Preferred Stock under the constructive sale provisions of the Code; persons that hold or receive our securities as part of a straddle, constructive sale, hedge, conversion or other integrated or similar transaction; persons subject to special tax accounting rules as a result of any item of gross income with respect to our Common Stock or Junior Series B Participating Preferred Stock being taken into account in an “applicable financial statement;” or U.S. Holders (as defined below) whose functional currency is not the U.S. dollar.
This discussion is based on the Code and Treasury Regulations promulgated under the Code, and judicial and administrative interpretations thereof, all as of the date hereof. All of the foregoing is subject to change, which change could apply retroactively and could affect the tax considerations described herein. This discussion does not address U.S. federal taxes not pertaining to U.S. federal income taxation (such as estate or gift taxes), the alternative minimum tax or the Medicare tax on investment income, nor does it address any aspects of U.S. state or local or non-U.S. taxation. There can be no assurance that the IRS will not assert positions contrary to those discussed herein or that any such positions would not be sustained by a court.
As used herein, the term “U.S. Holder” means a beneficial owner of Common Stock, and, upon the exchange of Common Stock, Junior Series B Participating Preferred Stock, that is, for U.S. federal income tax purposes: (i) an individual who is a citizen or resident of the United States, (ii) a corporation (or other entity that is treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the U.S. or any state thereof (including the District of Columbia), (iii) an estate whose income is subject to U.S. federal income tax regardless of its source or (iv) a trust if (A) a U.S. court can exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all substantial decisions of the trust; or (B) the trust has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person.
As used herein, the term “Non-U.S. Holder” means a beneficial owner of Common Stock, and upon the exchange of Common Stock, Junior Series B Participating Preferred Stock, that is neither a U.S. Holder nor a partnership (or any entity or arrangement so characterized for U.S. federal income tax purposes).
If a partnership (or any entity or arrangement so characterized for U.S. federal income tax purposes) holds shares of Common Stock, the tax treatment of such partnership and a person treated as a partner of such partnership will generally depend on the status of the partner and the activities of the partner and the partnership. Partnerships holding any shares of Common Stock and persons that are treated as partners of such partnerships should consult their tax advisors as to the particular U.S. federal income tax considerations applicable to them.
As described above, we have elected to be treated as a REIT for U.S. federal income tax purposes, and intend to maintain such treatment for the taxable year ending December 31, 2026. Under the C-Corp. Conversion Plan, the Board of Directors has determined that it is in the Company’s best interests to continue to maintain its REIT status for the taxable year ending December 31, 2026, and to remain in compliance with the requirements for taxation as a REIT during 2027 until such time as the Company makes the REIT Status Revocation Filing. We currently expect to make the REIT Status Revocation Filing with the IRS
 
51

Table of Contents
 
on or prior to March 31, 2027, as a result of which the Company would become a taxable C corporation effective January 1, 2027 (the “C-Corp. Conversion”). For a discussion of the considerations relevant to our status as a REIT and the ownership of our capital stock, including the Junior Series B Participating Preferred Stock, during the periods in which we qualify for taxation as a REIT prior to the C-Corp. Conversion, see the section of our Prospectus, contained within our Registration Statement filed with the SEC on March 3, 2025 (Registration Statement No. 333-285506) titled “Material U.S. Federal Income Tax Considerations” as amended through the date hereof.
THIS DISCUSSION OF U.S. FEDERAL INCOME TAX CONSIDERATIONS IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TAX ADVICE. HOLDERS OF COMMON STOCK SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE EXCHANGE OFFER AND THE OWNERSHIP AND DISPOSITION OF SHARES OF JUNIOR SERIES B PARTICIPATING PREFERRED STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.
U.S. Holders
Exchange of Common Stock for Junior Series B Participating Preferred Stock.   For those U.S. Holders of Common Stock participating in the Exchange Offer, we intend to treat your exchange of shares of Common Stock for Junior Series B Participating Preferred Stock as a “recapitalization” within the meaning of Section 368(a)(1)(E) of the Code. Assuming that such exchange is so treated, and subject to the discussion of “nonqualified preferred stock” below, for U.S. federal income tax purposes: (i) you should not recognize any gain or loss on the exchange of shares of Common Stock for Junior Series B Participating Preferred Stock (other than with respect to any cash received in lieu of a fractional share of Junior Series B Participating Preferred Stock); (ii) your aggregate tax basis in the Junior Series B Participating Preferred Stock received in the exchange should equal your aggregate tax basis in your Common Stock surrendered in the exchange (except to the extent of any tax basis allocated to a fractional share of Junior Series B Participating Preferred Stock for which a cash payment is received in connection with the exchange); and (iii) your holding period for the Junior Series B Participating Preferred Stock received in the exchange should include your holding period for the surrendered shares of Common Stock. Special tax basis and holding period rules apply to U.S. Holders that acquired different blocks of shares of Common Stock at different prices or at different times. You should consult your tax advisor as to the applicability of these special rules to your particular circumstances.
Any cash you receive in lieu of a fractional share of Junior Series B Participating Preferred Stock pursuant to the Exchange Offer should generally result in gain or loss to you equal to the difference between the cash received and your tax basis in the fractional share.
However, alternative characterizations of your exchange of shares of Common Stock for Junior Series B Participating Preferred Stock by the IRS or a court are possible, including ones that would require U.S. Holders to recognize taxable income on the exchange of shares of Common Stock for Junior Series B Participating Preferred Stock. If the exchange of shares of Common Stock for Junior Series B Participating Preferred Stock were not treated as a recapitalization for U.S. federal income tax purposes, or if the shares of Junior Series B Participating Preferred Stock are treated either as indebtedness, rather than equity, of the Company or as “nonqualified preferred stock,” exchanging U.S. Holders may recognize taxable gain or loss in an amount equal to the difference between (1) the amount realized upon such exchange and (2) the U.S. Holder’s tax basis in the exchanged shares of Common Stock. Such gain or loss would generally be treated as long-term capital gain or loss if the exchanged shares of Common Stock have been held by the U.S. Holder for more than one year at the time of such exchange. The deductibility of capital losses is subject to certain limitations. Although the Company will treat the Junior Series B Participating Preferred Stock as equity of the Company that is not “nonqualified preferred stock,” such determinations are highly factual, and no assurance can be given that the IRS would not challenge such treatment. This discussion assumes that such treatment is respected.
 
52

Table of Contents
 
Further, we expect the Junior Series B Participating Preferred Stock to constitute stock that is not “Section 306 stock” within the meaning of Section 306(c) of the Code. If, notwithstanding our expectation, the Junior Series B Participating Preferred Stock were determined to constitute Section 306 stock, a shareholder generally would be treated as realizing ordinary income as opposed to capital gain upon certain dispositions (including redemptions) of the Junior Series B Participating Preferred Stock. No assurance can be given that the IRS will treat the Junior Series B Participating Preferred Stock as other than Section 306 stock.
If you are a U.S. Holder and exchange shares of Common Stock for Junior Series B Participating Preferred Stock pursuant to the Exchange Offer, and if you hold five percent or more of our total outstanding stock prior to the exchange, or if you hold shares of Common Stock and other securities of ours prior to the exchange with a tax basis of $1.0 million or more, you will be required to file with your U.S. federal income tax return for the year in which the exchange occurs a statement setting forth certain information relating to the exchange (including the fair market value, prior to the exchange, of the shares of Common Stock transferred in the exchange and your tax basis, prior to the exchange, in Junior Series B Participating Preferred Stock or securities), and to maintain permanent records containing such information.
Distributions.   Distributions with respect to the Junior Series B Participating Preferred Stock will be taxable as dividend income when paid to the extent of our current or accumulated earnings and profits as determined for U.S. federal income tax purposes. To the extent that the amount of a distribution with respect to Junior Series B Participating Preferred Stock exceeds our current and accumulated earnings and profits, such distribution will be treated first as a tax-free return of capital to the extent of the U.S. Holder’s adjusted tax basis in the Junior Series B Participating Preferred Stock, and thereafter as capital gain which will be long-term capital gain if the U.S. Holder’s holding period for such stock exceeds one year at the time of the distribution. In determining the extent to which a distribution will be treated as being made from our earnings and profits, our earnings and profits will be allocated on a pro rata basis, first to distributions with respect to our preferred stock, and then to our common stock. Distributions constituting dividend income received by certain non-corporate U.S. Holders in respect of the Junior Series B Participating Preferred Stock will generally be subject to taxation at the preferential rates applicable to long-term capital gains, provided applicable holding period requirements are met and certain other conditions are satisfied. Distributions on the Junior Series B Participating Preferred Stock constituting dividend income paid to U.S. Holders that are U.S. corporations will generally qualify for the dividends received deduction, subject to various limitations.
Dividends that exceed certain thresholds in relation to a U.S. Holder’s tax basis in their shares of Junior Series B Participating Preferred Stock could be characterized as “extraordinary dividends” under the Code. Certain non-corporate U.S. Holders who receive an extraordinary dividend will generally be required to treat any losses on the sale of the shares of Junior Series B Participating Preferred Stock as long-term capital losses to the extent taxable dividend income received by them with respect to such shares of Junior Series B Participating Preferred Stock qualifies for the preferential rates applicable to long-term capital gains. If a corporate U.S. Holder that has held their shares of Junior Series B Participating Preferred Stock for two years or less before the dividend announcement date receives an extraordinary dividend, such holder will generally be required to reduce its tax basis in the shares of Junior Series B Participating Preferred Stock with respect to which such dividend was made by the non-taxed portion of such dividend. If the amount of the reduction exceeds the U.S. Holder’s tax basis in such shares of Junior Series B Participating Preferred Stock, the excess is treated as taxable gain.
Sale, Exchange, or Other Taxable Disposition.   A U.S. Holder will generally recognize capital gain or loss on a sale, exchange, redemption (other than a redemption that is treated as a distribution, as discussed below) or other disposition of the shares of Junior Series B Participating Preferred Stock equal to the difference between the amount realized upon the disposition and the U.S. Holder’s adjusted tax basis in the shares so disposed. Such capital gain or loss will be long-term capital gain or loss if the U.S. Holder’s holding period for the shares disposed of exceeds one year at the time of disposition. Long-term capital gains of noncorporate taxpayers are generally taxed at a lower maximum marginal tax rate than the maximum marginal tax rate applicable to ordinary income. The deductibility of net capital losses by individuals and corporations is subject to limitations.
A redemption of the shares of Junior Series B Participating Preferred Stock will be treated as a sale or exchange described in the preceding paragraph if the redemption (i) is “substantially disproportionate” with
 
53

Table of Contents
 
respect to the holder; (ii) results in a “complete termination” of the holder’s stock interest in us; or (iii) is “not essentially equivalent to a dividend” with respect to the holder, all within the meaning of Section 302(b) of the Code. If none of the alternative tests of Section 302(b) of the Code are met, the redemption will be treated as a distribution subject to the rules described under “U.S. Holders — Distributions,” above. Because the determination as to whether any of the alternative tests of Section 302(b) of the Code is satisfied with respect to any particular holder of the Junior Series B Participating Preferred Stock will depend upon the facts and circumstances as of the time the determination is made, holders should consult their tax advisors regarding the tax treatment to them of a redemption.
In the event that a redemption payment is properly treated as a distribution, the amount of the distribution will be equal to the amount of cash and the fair market value of property received without any offset for the U.S. Holder’s tax basis in the Junior Series B Participating Preferred Stock. Any tax basis in the redeemed shares of Junior Series B Participating Preferred Stock should be transferred to the U.S. Holder’s remaining equity interests in the Company. If the U.S. Holder has no remaining equity interests in the Company, such basis could, under certain circumstances, be transferred to any remaining equity interests in the Company that are held by a person related to such holder, or such basis could be lost entirely.
Non-U.S. Holders
Exchange of Common Stock for Junior Series B Participating Preferred Stock.   A Non-U.S. Holder’s exchange of shares of Common Stock for Junior Series B Participating Preferred Stock pursuant to the Exchange Offer should generally have the same tax consequences as described above for U.S. Holders. Any cash you receive in lieu of a fractional share of Junior Series B Participating Preferred Stock pursuant to the Exchange Offer should generally be treated as gain from the sale or other taxable disposition of shares of Junior Series B Participating Preferred Stock, and you should not be required to make any U.S. federal income tax filings solely on account of the exchange of shares of Common Stock for Junior Series B Participating Preferred Stock or the receipt of cash in lieu of a fractional share of Junior Series B Participating Preferred Stock.
Distributions.   Generally, distributions treated as dividends as described above under “U.S. Holders — Distributions,” paid to a Non-U.S. Holder with respect to the Junior Series B Participating Preferred Stock will be subject to a 30% U.S. withholding tax, or such lower rate as may be specified by an applicable income tax treaty. Distributions that are effectively connected with such Non-U.S. Holder’s conduct of a trade or business in the United States (and, if a tax treaty applies, are attributable to a U.S. permanent establishment of such holder) are generally subject to U.S. federal income tax on a net income basis and are exempt from the 30% withholding tax (assuming compliance with certain certification requirements and that we have no actual knowledge or reason to know that the certifications are incorrect). Any such effectively connected distributions received by a Non-U.S. Holder that is a corporation may also, under certain circumstances, be subject to an additional “branch profits tax” at a 30% rate or such lower rate as may be applicable under an income tax treaty.
For purposes of obtaining a reduced rate of withholding under an income tax treaty, a Non-U.S. Holder will generally be required to provide a U.S. taxpayer identification number as well as certain information concerning the holder’s country of residence and entitlement to tax treaty benefits. A Non-U.S. Holder can generally meet the certification requirements by providing a properly executed IRS Form W-8BEN or other applicable form (if the holder is claiming the benefits of an income tax treaty) or Form W-8ECI (if the dividends are effectively connected with a trade or business in the United States) or suitable substitute form (assuming the payor has no knowledge or reason to know that the certifications are incorrect).
Sale, Exchange, or Other Taxable Disposition.   A Non-U.S. Holder generally will not be subject to U.S. federal income or withholding tax on gain realized on the sale, exchange or other disposition (other than a redemption that is treated as a distribution as discussed below) of the shares of Junior Series B Participating Preferred Stock unless (i) the Non-U.S. Holder is a non-resident alien individual that is present in the United States for 183 or more days in the taxable year of the sale or disposition and certain other requirements are satisfied, (ii) the gain is effectively connected with the conduct by the Non-U.S. Holder of a trade or business within the United States (and, if a tax treaty applies, is attributable to a U.S. permanent establishment maintained by such Non-U.S. Holder), or (iii) we are or have been a “United States real property holding
 
54

Table of Contents
 
corporation” for United States federal income tax purposes at any time during the shorter of the five-year period ending on the date of the sale, exchange or other disposition and the period that the Non-U.S. Holder held the shares of Junior Series B Participating Preferred Stock and either (a) the Junior Series B Participating Preferred Stock had ceased to be traded on an established securities market prior to the beginning of the calendar year in which the sale, exchange or other disposition occurs or (b) the Non-U.S. Holder owns (actually or constructively) more than five percent of the shares of Junior Series B Participating Preferred Stock at some time during the shorter of the five-year period ending on the date of the sale, exchange or other disposition and the period that the Non-U.S. Holder held the shares of Junior Series B Participating Preferred Stock. Although there can be no assurances, we believe we are not a United States real property holding corporation, and we do not expect to become a United States real property holding corporation.
An individual Non-U.S. Holder described in clause (i) of the immediately preceding paragraph will be required to pay (subject to applicable income tax treaties) a flat 30% tax on the gain derived from the sale, which may be offset by certain United States source capital losses, even though the individual is not considered a resident of the United States. Gain described in clauses (ii) and (iii) of such paragraph will be subject to tax on a net income basis at regular graduated U.S. federal income tax rates in the same manner as if the Non-U.S. Holder were a United States person. A Non-U.S. Holder that is a corporation may also be subject to a branch profits tax equal to 30% (or at such lower rate as may be specified by an applicable income tax treaty) of its effectively connected earnings and profits for the taxable year, as adjusted for certain items.
A payment made to a Non-U.S. Holder in redemption of the shares of Junior Series B Participating Preferred Stock may be treated as a dividend, rather than as a payment in exchange for such stock, in the circumstances discussed above under “U.S. Holders — Sale, Exchange, or Other Taxable Disposition,” in which event such payment would be subject to tax as discussed above under “Non-U.S. Holders —  Distributions.”
Foreign Account Tax Compliance Act.   Under the Foreign Account Tax Compliance Act, withholding at a rate of 30% will generally be required on dividends in respect of shares of our Junior Series B Participating Preferred Stock held by or through certain foreign financial institutions (including investment funds), unless such institution (i) enters into an agreement with the U.S. Department of the Treasury to report, on an annual basis, information with respect to shares in, and accounts maintained by, the institution to the extent such shares or accounts are held by certain U.S. persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments, or (ii) complies with the terms of an intergovernmental agreement between the United States and an applicable foreign country. Accordingly, the entity through which shares of our Junior Series B Participating Preferred Stock are held will affect the determination of whether such withholding is required. Similarly, dividends in respect of shares of our Junior Series B Participating Preferred Stock held by an investor that is a non-financial non-U.S. entity that does not qualify under certain exemptions will be subject to withholding at a rate of 30%, unless such entity either (i) certifies that such entity does not have any “substantial United States owners” or (ii) provides certain information regarding the entity’s “substantial United States owners,” which we or the applicable withholding agent will in turn provide to the Secretary of the Treasury. An intergovernmental agreement between the United States and an applicable foreign country, or future Treasury regulations or other guidance, may modify these requirements. We will not pay any additional amounts to investors in respect of any amounts withheld. Non-U.S. investors are encouraged to consult their tax advisors regarding the possible implications of the legislation on their investment in our Junior Series B Participating Preferred Stock.
 
55

Table of Contents​
 
CERTAIN SECURITIES LAWS CONSIDERATIONS
The issuance of any shares of Junior Series B Participating Preferred Stock upon exchange of the Common Stock is exempt from registration pursuant to Section 3(a)(9) of the Securities Act. Section 3(a)(9) provides an exemption from registration for any security exchanged by an issuer with its existing security holders exclusively where no commission or other remuneration is paid or given directly or indirectly for soliciting such exchange. When securities are exchanged for other securities of an issuer under Section 3(a)(9), the securities received in essence assume the character of the exchanged securities for purposes of the Securities Act. Because all outstanding Common Stock was either registered under the Securities Act or is otherwise freely tradable under U.S. securities laws, we expect that all of our shares of Junior Series B Participating Preferred Stock issued in the Exchange Offer to persons not affiliated with us will be freely tradable under U.S. securities laws by such non-affiliates. Any shares of Junior Series B Participating Preferred Stock issued in the Exchange Offer to persons or entities who are affiliated with us would not be freely tradable and any resale would have to be registered under the Securities Act, or comply with applicable exemptions under the securities laws, which may include Rule 144 under the Securities Act. You are urged to consult with your own legal counsel regarding the availability of a resale exemption from the registration requirements of the Securities Act.
 
56

Table of Contents​
 
ABOUT THE COMPANY
Redwood Trust, Inc., together with its subsidiaries, is a specialty finance company focused on several distinct areas of housing credit, with a mission to make quality housing — whether rented or owned — accessible to all American households. Our operating platforms occupy a unique position in the housing finance value chain by providing liquidity to growing segments of the U.S. housing market that are not well served by government programs. We deliver customized housing credit investments to a diverse mix of investors, through our best-in-class securitization platforms, whole-loan distribution activities, joint ventures and our publicly traded shares. We operate through three residential housing-focused operating platforms — Sequoia, Aspire, and CoreVest — alongside our complementary Redwood Investments portfolio which is primarily composed of assets we source through these platforms. Redwood Investments also includes RWT Horizons®, our unified technology platform spanning internal artificial intelligence (“AI”) innovation and strategic investments across the ecosystem, which supports our efforts to develop an AI-first operating model that enables compounding operational leverage and scalable growth. These platforms reflect how we manage and organize our business and may differ from the manner in which our reportable segments are presented for financial reporting purposes.
 
57

Table of Contents​​
 
AVAILABLE INFORMATION
The Company files or furnishes reports, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements on Schedule 14A, and other information pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), with the Securities and Exchange Commission (the “Commission”). The SEC maintains a website that contains reports, proxy statements and other information about issuers, such as us, that file electronically with the SEC. The address of that website is http://www.sec.gov. Our public filings are also available to the public on our website at www.redwoodtrust.com. The information contained on our website, however, is not, and should not be deemed to be, a part of this Offer to Exchange or any other report or filing filed with the SEC.
INCORPORATION OF DOCUMENTS BY REFERENCE
The following documents filed by the Company with the Commission pursuant to the Exchange Act are incorporated herein by reference and shall be deemed to be a part hereof:
•
our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 27, 2026;
​
•
our Quarterly Reports on Form 10-Q for the quarter ended March 31, 2026, which was filed with the SEC on May 7, 2026, for the quarter ended June 30, 2026, which was filed with the SEC on August 5, 2026 and for the quarter ended September 30, 2026, which was filed with the SEC on November 9, 2026;
​
•
our Current Reports on Form 8-K, filed with the SEC on January 29, 2026, April 29, 2026, May 19, 2026, May 20, 2026, May 27, 2026, July 7, 2026, July 28, 2026, September 10, 2026, September 15, 2026 and November 3, 2026 (excluding the portions that were “furnished” in accordance with SEC rules);
​
•
our Definitive Proxy Statement with respect to the 2026 Annual Meeting of Stockholders, which was filed with the SEC on March 31, 2026 (solely to the extent specifically incorporated by reference into our Annual Report on Form 10-K for the fiscal year ended December 31, 2025);
​
•
the description of our common stock contained in Exhibit 4.1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the SEC on February 26, 2021, including any amendment or report filed with the SEC for the purpose of updating such description; and
​
•
all documents filed by Redwood Trust, Inc. with the SEC pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934, as amended, after the date of this Offer to Exchange and prior to the completion or termination of the Exchange Offer (but excluding any items, documents, or portions of items or documents which are deemed “furnished” and not filed with the SEC).
​
The Company is not, however, incorporating by reference any other reports, information or materials filed with the Commission or any other material from its website or any other source.
All press releases issued by the Company after the date of this Offer to Exchange and on or prior to the earlier of the Expiration Date or termination of the Offer to Exchange that indicate that they are to be deemed to be incorporated into this Offer to Exchange shall be deemed incorporated herein by reference and shall be deemed to be a part hereof from the date of issuance of such documents.
Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Offer to Exchange to the extent that a statement contained herein or in any subsequently issued document or report that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Offer to Exchange.
The Company will provide without charge to each person to whom this Offer to Exchange is delivered, upon written request, a copy of any and all of the documents that have been or may be incorporated by reference in this Offer to Exchange, other than exhibits to such documents which are not specifically
 
58

Table of Contents
 
incorporated herein. You should direct requests for documents to the Information Agent at its address set forth on the back cover page of this Offer to Exchange. You can also find additional information by visiting our website at: www.redwoodtrust.com. Information contained on our website is not part of, and is not incorporated into, this Offer to Exchange.
No person has been authorized to give any information or to make any representation not contained in this Offer to Exchange and, if given or made, such information or representation may not be relied upon as having been authorized by the Company, the Exchange Agent, or the Information Agent.
The Exchange Agent for the Exchange Offer is:
Computershare Trust Company, N.A.
C/O Voluntary Corporate Actions
150 Royall St, Suite V
Canton, MA 02021
​
By First Class, Registered or Certified Mail:
​ ​
By Express or Overnight Delivery:
​
​
Computershare Trust Company, N.A.
c/o Voluntary Corporate Actions
PO Box 43011
Providence, RI 02940-3011
​ ​
Computershare Trust Company, N.A.
c/o Voluntary Corporate Actions
150 Royall Street, Suite V
Canton, MA 02021
​
The Information Agent for the Exchange Offer is:
MacKenzie Partners, Inc.
7 Penn Plaza, Suite 503
New York, New York 10001
Call Toll-Free: (800) 322-2885
E-mail: RWT-MPI@mackenziepartners.com
 
59